data_2eqs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.467 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.463 ' CG1' HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.466 ' HE2' ' CE1' ' A' ' 281' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 276' ' ' MET . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 291' ' ' TRP . 44.9 tp60 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.468 ' O ' ' NE2' ' A' ' 283' ' ' GLN . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.435 HD12 ' CD1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.817 0.342 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.443 ' CE1' ' HE2' ' A' ' 276' ' ' MET . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.567 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 275' ' ' ILE . 3.1 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.529 ' ND2' ' HZ1' ' A' ' 320' ' ' LYS . 1.1 m120 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.423 ' CG1' ' CD1' ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.423 ' CD1' ' CG1' ' A' ' 272' ' ' VAL . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.421 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.421 ' CZ2' ' HD2' ' A' ' 289' ' ' LYS . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.444 ' CD1' ' HE1' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 298' ' ' SER . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 297' ' ' ILE . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' A' ' 313' ' ' VAL . 61.2 t . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.412 ' C ' HD12 ' A' ' 275' ' ' ILE . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . 0.529 ' HZ1' ' ND2' ' A' ' 269' ' ' ASN . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.541 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 300' ' ' LEU . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.455 HD22 ' CG1' ' A' ' 295' ' ' VAL . 42.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.861 0.362 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.4 ' C ' HG11 ' A' ' 313' ' ' VAL . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.4 HG11 ' C ' ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.432 ' CD1' HG21 ' A' ' 323' ' ' VAL . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.421 ' CG1' ' CD1' ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 272' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.422 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.435 ' CG1' HD23 ' A' ' 300' ' ' LEU . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.426 ' CE1' HG23 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.426 HG23 ' CE1' ' A' ' 296' ' ' HIS . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.435 HD23 ' CG1' ' A' ' 295' ' ' VAL . 80.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 312' ' ' VAL . 75.7 t . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.861 0.363 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 309' ' ' VAL . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.432 HG21 ' CD1' ' A' ' 268' ' ' TYR . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.427 ' ND2' ' HZ1' ' A' ' 320' ' ' LYS . 1.6 m120 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.422 HD12 ' C ' ' A' ' 314' ' ' SER . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.565 ' HE2' ' CE1' ' A' ' 281' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.481 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.459 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 278' ' ' PHE . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.463 ' CD1' HG23 ' A' ' 309' ' ' VAL . 66.2 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 300' ' ' LEU . 47.3 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.422 ' C ' HD12 ' A' ' 275' ' ' ILE . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . 0.427 ' HZ1' ' ND2' ' A' ' 269' ' ' ASN . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.411 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.486 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 312' ' ' VAL . 41.4 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.856 0.36 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 309' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 345' ' ' ASP . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 322' ' ' LYS . 3.9 t0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.481 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.474 ' CE2' HD12 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.481 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.474 HD12 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.877 0.37 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 335' ' ' MET . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.469 ' CB ' ' CG2' ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.415 HD22 ' NZ ' ' A' ' 322' ' ' LYS . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' MET . . . . . 0.432 ' CG ' HG11 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.443 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' VAL . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.443 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . 0.431 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.407 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 339' ' ' ASP . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.46 ' N ' HG13 ' A' ' 338' ' ' VAL . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.431 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 276' ' ' MET . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.46 ' CA ' ' HE3' ' A' ' 276' ' ' MET . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.86 0.362 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 339' ' ' ASP . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.439 ' N ' HG11 ' A' ' 338' ' ' VAL . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' A' ' 281' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.441 ' CG1' HD21 ' A' ' 300' ' ' LEU . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.441 HD21 ' CG1' ' A' ' 295' ' ' VAL . 76.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 312' ' ' VAL . 43.4 t . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.859 0.361 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.477 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.462 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 281' ' ' PHE . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.434 ' CE2' ' HE2' ' A' ' 276' ' ' MET . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 271' ' ' LYS . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.477 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.508 ' CE1' HG23 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 296' ' ' HIS . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.424 ' N ' HG21 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 57.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 312' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 309' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.407 ' C ' HG23 ' A' ' 338' ' ' VAL . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.452 ' N ' HG23 ' A' ' 338' ' ' VAL . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 337' ' ' ASP . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 322' ' ' LYS . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.424 ' HD2' ' C ' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.566 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.566 ' CZ2' ' HG2' ' A' ' 289' ' ' LYS . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.416 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.415 ' N ' HG23 ' A' ' 297' ' ' ILE . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.82 0.343 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.427 HG21 ' N ' ' A' ' 343' ' ' GLY . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 342' ' ' THR . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 268' ' ' TYR . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 267' ' ' ILE . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.466 ' CD1' ' HD3' ' A' ' 315' ' ' LYS . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.465 ' CG1' HD22 ' A' ' 300' ' ' LEU . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.465 HD22 ' CG1' ' A' ' 295' ' ' VAL . 23.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.458 ' CG2' ' HB ' ' A' ' 297' ' ' ILE . 95.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 309' ' ' VAL . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.466 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.459 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 337' ' ' ASP . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 344' ' ' GLU . 7.8 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 261' ' ' GLU . 7.2 pt-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.404 ' H ' ' CG ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.473 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.515 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.473 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.838 0.351 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.47 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.422 ' CG ' ' HG2' ' A' ' 341' ' ' GLU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.522 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.476 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.552 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.522 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.426 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 312' ' ' VAL . 3.1 t . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . 0.476 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . 0.411 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.411 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 268' ' ' TYR . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.547 ' CD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 275' ' ' ILE . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.424 ' CD1' HG13 ' A' ' 272' ' ' VAL . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.446 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.559 HD12 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 298' ' ' SER . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.406 ' N ' HG21 ' A' ' 297' ' ' ILE . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 312' ' ' VAL . 59.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 309' ' ' VAL . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 343' ' ' GLY . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.408 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.439 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.472 ' CG1' HG21 ' A' ' 313' ' ' VAL . 48.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.84 0.352 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.472 HG21 ' CG1' ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . 0.452 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.467 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB2' ' CB ' ' A' ' 332' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.539 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . 0.452 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 264' ' ' ILE . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 263' ' ' THR . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.419 ' HD2' ' C ' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.556 ' HE3' ' CE1' ' A' ' 281' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.556 ' CE1' ' HE3' ' A' ' 276' ' ' MET . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.442 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.528 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 312' ' ' VAL . 18.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 309' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.452 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 265' ' ' GLY . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 264' ' ' ILE . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.516 ' CE1' ' HE3' ' A' ' 276' ' ' MET . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.401 HD11 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.405 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 296' ' ' HIS . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 276' ' ' MET . 4.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.834 0.35 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.424 ' C ' HG21 ' A' ' 338' ' ' VAL . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -85.78 96.67 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 67.8 m -161.66 133.1 5.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.34 -111.38 2.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.0 m 59.21 42.78 18.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.1 p -53.06 138.73 30.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -153.08 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.467 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 -47.74 -42.8 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.467 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.463 ' CG1' HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.466 ' HE2' ' CE1' ' A' ' 281' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 276' ' ' MET . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 291' ' ' TRP . 44.9 tp60 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.468 ' O ' ' NE2' ' A' ' 283' ' ' GLN . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.435 HD12 ' CD1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 84.2 mt -130.61 -50.1 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -123.9 172.06 9.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 304' ' ' GLY . 7.3 tpt180 -75.5 159.36 31.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -38.64 95.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 302' ' ' ARG . . . -165.13 -144.24 3.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -118.44 115.02 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.37 129.61 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.47 -70.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.17 154.93 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.31 -30.54 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.92 105.18 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.29 32.57 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -123.45 80.74 53.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.627 0.727 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.48 12.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.93 139.82 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -164.97 150.07 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -133.25 141.26 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 164.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.08 -52.05 2.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.09 150.63 30.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.88 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 53.5 p -107.31 109.65 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -132.78 -52.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 129.54 -157.77 21.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.1 p -96.26 87.12 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 84.3 p -143.86 113.96 7.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -115.1 46.14 1.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -99.89 -42.56 6.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.443 ' CE1' ' HE2' ' A' ' 276' ' ' MET . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.567 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.77 -67.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.462 ' HG2' ' CG2' ' A' ' 306' ' ' VAL . 7.6 ptt180 -122.19 162.46 21.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -40.46 137.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -44.56 100.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.24 -132.31 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -119.7 69.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.462 ' CG2' ' HG2' ' A' ' 301' ' ' ARG . 93.0 t -96.03 136.25 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' HG13 ' A' ' 306' ' ' VAL . . . -121.24 -57.13 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.55 157.34 16.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 275' ' ' ILE . 3.1 t -108.01 -15.5 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 346' ' ' LEU . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.8 97.18 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.465 ' CG ' ' O ' ' A' ' 337' ' ' ASP . 14.1 mt -88.64 39.81 0.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 322' ' ' LYS . 1.2 t30 -107.93 76.85 0.61 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -45.42 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.374 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.2 m120 -130.15 -35.99 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 349' ' ' ASN . 10.0 tpp180 -34.53 106.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -158.35 160.2 36.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.827 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -140.68 146.6 38.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -65.99 127.98 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.18 -53.84 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.7 m -108.36 90.07 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 m -66.41 102.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 54.23 -138.41 39.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.5 p -48.32 -52.23 22.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.0 m 48.18 41.24 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.81 84.05 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.23 -46.57 86.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.529 ' ND2' ' HZ1' ' A' ' 320' ' ' LYS . 1.1 m120 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.423 ' CG1' ' CD1' ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.423 ' CD1' ' CG1' ' A' ' 272' ' ' VAL . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.421 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.421 ' CZ2' ' HD2' ' A' ' 289' ' ' LYS . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.444 ' CD1' ' HE1' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 298' ' ' SER . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 297' ' ' ILE . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt -134.21 -68.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -103.85 114.55 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 33.6 ptt85 -71.31 -38.56 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 7.0 tp10 -130.49 107.07 8.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 143.5 159.88 8.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 36.9 mtp85 -94.22 119.04 32.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.861 0.362 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 137.25 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.44 -33.49 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -127.58 177.93 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' A' ' 313' ' ' VAL . 61.2 t -117.8 -28.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.412 ' C ' HD12 ' A' ' 275' ' ' ILE . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.529 ' HZ1' ' ND2' ' A' ' 269' ' ' ASN . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.35 96.19 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.74 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -130.42 74.41 80.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.23 5.93 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -105.56 63.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -138.48 108.01 6.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -107.49 -61.47 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.13 105.04 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -132.99 152.25 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.46 -49.94 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -82.16 -55.07 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.6 p -126.66 119.09 26.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -44.06 167.02 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.476 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.4 t -125.94 84.55 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.1 t -134.19 138.52 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -177.34 -54.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.98 -47.84 5.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.541 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 300' ' ' LEU . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.455 HD22 ' CG1' ' A' ' 295' ' ' VAL . 42.5 mt -128.15 -63.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.43 123.91 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -70.68 -42.12 71.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -144.34 127.48 16.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 117.21 -174.87 15.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.77 137.13 35.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 144.71 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -100.28 -66.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -155.96 135.94 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 39.1 t -53.41 -36.62 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.4 ' C ' HG11 ' A' ' 313' ' ' VAL . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.4 HG11 ' C ' ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.54 108.57 7.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.57 34.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -125.14 80.91 63.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.681 0.753 . . . . 0.0 110.876 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -29.48 23.68 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.324 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -170.06 120.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -101.98 150.81 22.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.77 -66.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 354' ' ' LEU . 3.3 tpm_? -167.88 137.68 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -54.32 83.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 352' ' ' ARG . 6.9 tt -57.87 118.76 5.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.83 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 54.7 p -47.92 149.59 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.4 t -137.13 112.0 8.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 80.85 -87.69 1.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t 44.96 41.93 5.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 33.0 m -135.21 159.32 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.05 44.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -102.77 -46.53 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.432 ' CD1' HG21 ' A' ' 323' ' ' VAL . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.421 ' CG1' ' CD1' ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 272' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.42 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.422 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.435 ' CG1' HD23 ' A' ' 300' ' ' LEU . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.426 ' CE1' HG23 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.426 HG23 ' CE1' ' A' ' 296' ' ' HIS . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.435 HD23 ' CG1' ' A' ' 295' ' ' VAL . 80.0 mt -131.78 -56.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -129.83 148.21 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -102.87 -68.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -81.93 110.85 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.868 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 120.34 128.93 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -68.25 92.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.2 t -43.84 150.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 309' ' ' VAL . 67.0 t30 -150.92 129.54 12.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 312' ' ' VAL . 75.7 t -34.22 -50.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 309' ' ' VAL . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.432 HG21 ' CD1' ' A' ' 268' ' ' TYR . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.72 119.11 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.21 23.21 11.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -119.63 80.72 23.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.923 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 349' ' ' ASN . 53.9 Cg_endo -69.77 -21.85 32.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 348' ' ' PRO . 9.2 m120 -161.82 130.64 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -149.05 148.52 29.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -74.2 116.05 14.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -106.64 110.46 22.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -107.64 115.43 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 26.8 tp -146.89 131.4 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.4 m -98.66 143.42 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.5 p -40.52 121.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.72 94.64 2.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.7 t -74.02 133.54 42.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 m -91.96 -58.58 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.826 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 84.56 -53.84 4.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -76.58 -57.83 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.427 ' ND2' ' HZ1' ' A' ' 320' ' ' LYS . 1.6 m120 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.422 HD12 ' C ' ' A' ' 314' ' ' SER . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.565 ' HE2' ' CE1' ' A' ' 281' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.481 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.459 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.463 ' CG1' HG13 ' A' ' 306' ' ' VAL . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.463 ' CD1' HG23 ' A' ' 309' ' ' VAL . 66.2 mt -133.7 -64.75 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -74.99 161.42 29.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -35.64 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.78 -43.7 62.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 145.82 -78.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -47.49 140.42 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.463 HG13 ' CG1' ' A' ' 297' ' ' ILE . 60.2 t -137.92 138.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.12 -69.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -160.05 139.69 11.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 300' ' ' LEU . 47.3 t -58.23 -41.58 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.422 ' C ' HD12 ' A' ' 275' ' ' ILE . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.427 ' HZ1' ' ND2' ' A' ' 269' ' ' ASN . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.45 98.4 9.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.22 39.3 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -132.34 84.33 52.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.636 0.732 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -44.41 2.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.37 144.01 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.6 ttp85 -140.08 118.18 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -82.97 111.15 18.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.05 100.49 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -124.79 158.67 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.15 122.39 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 62.6 m -86.44 -53.42 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.895 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.6 t -123.72 -59.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 85.85 -178.15 49.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.5 t -102.68 103.13 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.0 m -50.34 -47.64 55.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.49 45.99 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -102.49 -53.85 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.411 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.486 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 15.9 mt -119.73 -49.6 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -132.39 174.72 9.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -121.16 -52.59 2.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -84.51 -75.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -52.58 140.63 29.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -71.76 157.43 37.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.85 98.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.16 -46.99 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -176.08 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 312' ' ' VAL . 41.4 t -121.25 -32.12 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 309' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 345' ' ' ASP . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.412 ' C ' HD13 ' A' ' 346' ' ' LEU . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 322' ' ' LYS . 3.9 t0 -61.88 103.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 337' ' ' ASP . 52.5 mt -76.86 -37.63 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.26 81.59 3.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.605 0.717 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -17.62 37.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 0.0 112.371 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -114.05 122.79 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -107.83 -60.56 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -98.56 146.58 25.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -98.0 113.84 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.52 -60.36 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.41 120.3 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.3 t -124.34 101.54 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 0.0 110.864 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.6 t -52.51 98.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 167.41 100.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -137.39 127.49 26.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 64.4 p -113.38 115.08 27.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.61 -38.91 1.68 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.65 -57.73 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.481 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.474 ' CE2' HD12 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.481 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.474 HD12 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 43.6 mt -133.71 -59.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -119.39 132.97 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -51.63 169.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -40.63 120.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 173.57 -130.81 1.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -129.9 105.53 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 307' ' ' ALA . 48.5 t -104.77 140.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.462 ' N ' HG11 ' A' ' 306' ' ' VAL . . . -90.39 -68.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.454 ' ND2' ' HB1' ' A' ' 310' ' ' ALA . 18.8 p-10 -158.02 169.93 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.21 -29.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.454 ' HB1' ' ND2' ' A' ' 308' ' ' ASN . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 308' ' ' ASN . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 335' ' ' MET . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.469 ' CB ' ' CG2' ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.415 HD22 ' NZ ' ' A' ' 322' ' ' LYS . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' MET . . . . . 0.432 ' CG ' HG11 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -93.11 104.87 17.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 43.6 mt -79.24 -32.73 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -127.87 87.99 54.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 1.28 4.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -157.37 113.07 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 160.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -74.9 -43.94 51.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -75.1 -50.83 15.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -41.18 134.76 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.91 -59.38 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.15 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 35.2 t -72.18 129.57 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 99.9 p -99.64 176.67 5.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -40.21 -73.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.6 m -113.97 169.93 8.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.6 m -150.43 121.92 7.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -176.5 66.89 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.75 -55.88 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.443 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' VAL . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.443 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 80.5 mt -123.84 -49.67 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' A' ' 306' ' ' VAL . 61.7 mtt180 -139.16 112.52 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -51.76 -48.34 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.38 -48.31 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -39.32 111.3 0.19 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -55.3 104.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 301' ' ' ARG . 99.2 t -78.81 112.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -75.02 -63.62 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -150.0 128.4 12.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t -43.92 -43.54 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.431 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.407 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 339' ' ' ASP . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.46 ' N ' HG13 ' A' ' 338' ' ' VAL . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.431 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -38.45 118.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.414 HD12 ' C ' ' A' ' 338' ' ' VAL . 78.6 mt -98.05 -23.87 15.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -120.75 77.21 29.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -45.77 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.256 . . . . 0.0 112.389 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 350' ' ' ARG . 2.0 p-10 -39.34 -44.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 349' ' ' ASN . 27.2 ttt180 -34.98 -46.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -56.88 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -86.76 97.51 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -74.8 159.03 32.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 15.1 tp -171.34 131.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.151 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.4 t -48.16 103.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -109.91 41.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 124.75 -158.75 19.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.421 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.6 m -96.07 88.48 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -83.51 146.76 28.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 287' ' ' LEU . . . 157.98 -71.93 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.82 -43.45 69.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 276' ' ' MET . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.46 ' CA ' ' HE3' ' A' ' 276' ' ' MET . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 259' ' ' GLY . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 62.8 mt -128.39 -33.61 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.406 ' NH1' ' HA ' ' A' ' 305' ' ' ARG . 15.8 ptt85 -124.01 122.75 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -62.76 -56.49 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.72 139.32 29.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 132.37 -134.23 7.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . 0.406 ' HA ' ' NH1' ' A' ' 301' ' ' ARG . 20.0 ttm-85 -171.06 127.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.436 HG13 ' CG2' ' A' ' 312' ' ' VAL . 86.7 t -121.2 148.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.85 163.52 39.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.87 -33.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 306' ' ' VAL . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 339' ' ' ASP . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.439 ' N ' HG11 ' A' ' 338' ' ' VAL . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -89.97 105.62 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.5 36.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -126.58 81.08 68.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.0 6.95 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.714 2.276 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -141.07 105.33 4.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 351' ' ' ARG . 23.9 ttp180 -93.48 -61.91 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 350' ' ' ARG . 7.2 tpp85 -34.5 99.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.09 85.74 7.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.71 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -44.89 117.86 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.9 p -97.28 97.34 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.0 p -164.65 141.77 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 67.77 121.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.1 m -136.65 140.26 42.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.7 t -54.37 156.88 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 164.88 -41.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -75.64 -58.63 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' A' ' 281' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.441 ' CG1' HD21 ' A' ' 300' ' ' LEU . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.441 HD21 ' CG1' ' A' ' 295' ' ' VAL . 76.5 mt -134.49 -65.21 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.415 ' CB ' HG21 ' A' ' 306' ' ' VAL . 16.9 ttp180 -102.49 162.12 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -93.78 -42.9 8.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -44.31 169.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -42.82 -94.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -104.32 153.92 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 297' ' ' ILE . 22.5 t -104.13 150.24 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 306' ' ' VAL . . . -70.81 -68.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.86 146.97 18.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 312' ' ' VAL . 43.4 t -64.36 -41.46 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 -89.81 99.12 12.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 347' ' ' ASN . 65.3 mt -88.44 -39.42 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -29.34 93.34 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.4 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 0.0 112.331 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 351' ' ' ARG . 1.0 OUTLIER -163.71 123.39 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -79.47 -51.96 8.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.473 ' O ' ' ND2' ' A' ' 349' ' ' ASN . 14.7 tpp85 -49.0 143.46 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . 0.423 ' HD3' ' C ' ' A' ' 352' ' ' ARG . 0.9 OUTLIER -113.58 -33.52 5.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 354' ' ' LEU . 7.6 t30 -142.93 133.71 25.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 354' ' ' LEU . 0.0 OUTLIER -143.05 -179.15 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 m -98.96 167.57 10.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.5 t -63.67 99.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 153.63 90.31 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.1 t -58.32 168.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.4 p -97.55 -59.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 287' ' ' LEU . . . 115.24 -69.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.61 -49.23 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.477 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.462 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 281' ' ' PHE . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.434 ' CE2' ' HE2' ' A' ' 276' ' ' MET . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 271' ' ' LYS . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.401 ' CD2' ' O ' ' A' ' 259' ' ' GLY . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.477 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.508 ' CE1' HG23 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 296' ' ' HIS . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.424 ' N ' HG21 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 57.7 mt -134.99 -40.76 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 301' ' ' ARG . 0.0 OUTLIER -126.17 136.21 52.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 12.4 ptt-85 -83.27 -38.11 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 8.2 tp10 -138.41 150.66 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.61 -161.99 19.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.53 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . 0.42 ' C ' ' HD2' ' A' ' 305' ' ' ARG . 4.4 tmm_? -143.02 114.22 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.47 HG12 ' CG2' ' A' ' 312' ' ' VAL . 64.7 t -103.52 138.61 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.169 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 306' ' ' VAL . . . -46.15 -70.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 297' ' ' ILE . 10.1 t30 -159.9 172.2 18.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 312' ' ' VAL . 13.0 t -53.23 -38.08 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.47 ' CG2' HG12 ' A' ' 306' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.407 ' C ' HG23 ' A' ' 338' ' ' VAL . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.452 ' N ' HG23 ' A' ' 338' ' ' VAL . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 301' ' ' ARG . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.413 ' CG ' ' HB3' ' A' ' 347' ' ' ASN . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 322' ' ' LYS . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.67 98.74 11.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.81 -40.64 28.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.413 ' HB3' ' CG ' ' A' ' 337' ' ' ASP . 35.4 t-20 -134.65 87.69 30.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -31.01 21.5 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -141.38 134.31 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 351' ' ' ARG . 0.0 OUTLIER -114.84 -28.94 6.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.43 ' N ' ' HG2' ' A' ' 350' ' ' ARG . 1.9 tmm_? -108.47 129.1 55.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -42.51 155.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -93.38 92.32 7.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 354' ' ' LEU . 0.6 OUTLIER -48.15 -60.62 2.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 34.4 t -96.52 122.32 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 p -112.32 -34.41 5.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 76.83 -140.57 25.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.5 p -107.69 175.39 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 59.7 m -124.08 -60.25 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 142.03 -40.39 1.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -87.95 -57.31 2.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.566 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.566 ' CZ2' ' HG2' ' A' ' 289' ' ' LYS . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.416 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.415 ' N ' HG23 ' A' ' 297' ' ' ILE . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt -132.17 -34.04 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.453 ' NH1' ' HB2' ' A' ' 301' ' ' ARG . 0.0 OUTLIER -123.55 177.18 5.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -107.19 -43.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -163.51 138.69 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 152.34 -140.19 7.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . 0.416 ' C ' HG21 ' A' ' 306' ' ' VAL . 15.6 tpt180 -149.74 105.92 3.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 305' ' ' ARG . 4.2 t -141.18 137.82 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.27 41.34 3.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -159.79 173.99 15.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 92.0 t -134.69 -36.29 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.427 HG21 ' N ' ' A' ' 343' ' ' GLY . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 342' ' ' THR . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.91 102.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.94 -36.05 64.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.14 81.31 1.25 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.639 0.733 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -43.12 2.81 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.335 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -92.05 103.26 15.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 ttt-85 -123.49 94.47 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 12.2 mtm105 -119.32 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -60.0 -42.66 94.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -162.08 154.24 19.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 355' ' ' VAL . 19.3 tp -108.73 107.47 17.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 354' ' ' LEU . 14.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.104 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 38.7 p -61.66 126.14 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.6 t -102.92 129.08 49.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 146.99 -177.22 25.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 67.5 m -95.3 116.67 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.7 t -130.03 91.7 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.45 59.42 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER -109.62 -54.39 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 268' ' ' TYR . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 267' ' ' ILE . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.466 ' CD1' ' HD3' ' A' ' 315' ' ' LYS . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.465 ' CG1' HD22 ' A' ' 300' ' ' LEU . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.465 HD22 ' CG1' ' A' ' 295' ' ' VAL . 23.8 mt -71.1 -63.15 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -98.97 125.68 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -82.87 -34.54 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -39.66 -52.18 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 148.89 -126.84 2.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -42.72 128.41 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.445 HG12 ' CG1' ' A' ' 297' ' ' ILE . 82.0 t -121.21 138.28 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -62.39 -72.28 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.115 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -157.89 138.6 13.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.912 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.458 ' CG2' ' HB ' ' A' ' 297' ' ' ILE . 95.6 t -52.02 -48.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 309' ' ' VAL . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.466 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.459 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 337' ' ' ASP . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.413 ' CG ' HD21 ' A' ' 346' ' ' LEU . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 344' ' ' GLU . 7.8 t0 -79.66 86.31 5.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.5 ' O ' ' C ' ' A' ' 347' ' ' ASN . 8.7 mt -70.19 -34.44 72.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 346' ' ' LEU . 21.0 t-20 -29.16 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.583 0.706 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.6 Cg_endo -69.79 -37.62 8.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.239 . . . . 0.0 112.366 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -146.45 134.42 21.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 351' ' ' ARG . 5.9 tpt180 -114.39 -51.07 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.418 ' HD3' ' C ' ' A' ' 351' ' ' ARG . 0.0 OUTLIER -37.35 145.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.33 164.45 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.67 52.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.77 95.49 5.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 67.3 m 39.44 45.15 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.3 t -102.47 86.16 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 151.01 122.47 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.3 t -110.65 -53.25 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.8 t -99.62 123.33 43.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -129.55 166.5 21.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 261' ' ' GLU . 7.2 pt-20 -108.85 -56.48 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.404 ' H ' ' CG ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.473 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.515 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.473 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 39.2 mt -117.13 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.425 ' CG ' HG23 ' A' ' 306' ' ' VAL . 9.4 ptp180 -160.41 113.06 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -57.05 -42.37 80.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 303' ' ' GLU . 6.3 pt-20 -66.84 109.85 3.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 93.44 141.93 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -84.61 83.51 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.425 HG23 ' CG ' ' A' ' 301' ' ' ARG . 37.0 t -62.01 154.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -133.98 -52.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.441 ' O ' ' CG2' ' A' ' 312' ' ' VAL . 8.9 t-20 -103.61 134.38 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 26.2 t -83.31 -25.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 308' ' ' ASN . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.47 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.438 ' N ' HD13 ' A' ' 346' ' ' LEU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.85 95.6 10.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 339' ' ' ASP . 18.5 mt -83.39 20.07 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 12.7 t-20 -114.26 64.28 1.34 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.634 0.73 . . . . 0.0 110.912 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -50.74 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -141.83 115.53 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.41 ' C ' ' HD2' ' A' ' 351' ' ' ARG . 49.5 ttp85 -98.61 49.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.41 ' HD2' ' C ' ' A' ' 350' ' ' ARG . 5.2 mpt_? -133.19 42.37 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -125.14 -50.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.61 144.17 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 25.5 mt -143.67 110.97 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.6 t -95.26 120.66 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.4 p -60.06 -35.63 75.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 38.87 66.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.4 t 71.14 47.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 41.3 t -75.0 109.34 8.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -165.38 55.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -103.0 -58.82 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.522 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.476 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.552 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.522 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.426 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt -133.34 -57.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -120.96 136.46 54.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -99.11 -64.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.438 ' C ' ' CD ' ' A' ' 303' ' ' GLU . 0.3 OUTLIER -96.82 104.66 16.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 137.12 -164.2 25.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -117.09 155.18 29.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.92 127.85 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -90.01 -58.49 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.7 137.35 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 312' ' ' VAL . 3.1 t -52.1 -39.52 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . 0.476 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.411 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.411 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.85 99.41 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.14 -38.55 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.82 84.96 9.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.63 0.729 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -34.87 13.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -131.42 101.33 5.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -84.76 179.0 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -133.76 127.21 32.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 48.2 ttm-85 -123.13 108.32 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -142.41 129.52 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.65 -56.89 3.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 44.4 t -73.8 118.45 16.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 m -69.72 166.86 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 130.0 -54.57 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 38.7 m 46.77 42.42 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.3 t -86.91 82.06 7.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.89 98.06 0.34 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.38 -52.57 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 268' ' ' TYR . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.547 ' CD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 275' ' ' ILE . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.424 ' CD1' HG13 ' A' ' 272' ' ' VAL . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.446 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.559 HD12 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 298' ' ' SER . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.406 ' N ' HG21 ' A' ' 297' ' ' ILE . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 72.4 mt -127.25 -53.69 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -122.29 143.27 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -43.56 165.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -41.58 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -171.95 -135.72 2.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -135.38 123.72 23.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 297' ' ' ILE . 58.9 t -109.32 143.99 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.18 -69.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -155.51 151.81 28.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 312' ' ' VAL . 59.4 t -62.09 -42.84 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 309' ' ' VAL . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.547 HG23 ' CD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 343' ' ' GLY . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER -83.71 93.39 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.91 -32.53 72.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -114.54 81.8 7.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.65 0.738 . . . . 0.0 110.817 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -44.08 2.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -130.5 113.3 14.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -101.52 43.63 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.79 133.41 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -138.08 151.25 47.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -63.39 133.54 54.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.24 118.38 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.3 t -83.34 44.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.8 p -108.72 41.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.22 147.95 18.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 76.7 p -119.45 41.9 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -94.73 129.34 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 170.32 125.78 0.83 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.68 -55.54 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.408 ' CE2' ' HE1' ' A' ' 276' ' ' MET . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.439 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt -131.24 -46.25 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -118.65 138.91 52.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -84.9 -72.92 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.81 148.63 27.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.67 148.45 22.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.58 132.52 43.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.77 140.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.9 -72.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -155.86 149.86 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.472 ' CG1' HG21 ' A' ' 313' ' ' VAL . 48.4 t -46.63 -43.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.472 HG21 ' CG1' ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.452 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.467 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB2' ' CB ' ' A' ' 332' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.539 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . 0.452 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 348' ' ' PRO . 1.4 t70 -95.58 92.8 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 29.6 mt -65.72 -30.76 71.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -127.79 84.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.49 ' N ' ' OD1' ' A' ' 345' ' ' ASP . 53.6 Cg_endo -69.72 -44.2 2.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.05 138.81 43.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -132.84 132.96 42.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -44.04 110.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 9.8 tpt85 -81.36 92.21 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -131.5 172.27 12.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.77 41.57 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 26.5 t -91.98 131.72 37.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.2 p -142.68 153.85 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -79.55 -112.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -99.58 86.22 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.1 t -85.12 128.12 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.841 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.43 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.67 -47.9 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 264' ' ' ILE . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 263' ' ' THR . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.419 ' HD2' ' C ' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.556 ' HE3' ' CE1' ' A' ' 281' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.556 ' CE1' ' HE3' ' A' ' 276' ' ' MET . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.442 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.528 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 40.7 mt -118.21 -50.16 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -93.93 161.21 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.58 -62.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.68 55.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -170.26 178.89 42.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -119.86 153.75 35.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.416 HG13 ' CG2' ' A' ' 312' ' ' VAL . 20.4 t -145.65 136.28 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -51.21 -59.52 4.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.423 ' ND2' ' HB1' ' A' ' 310' ' ' ALA . 0.4 OUTLIER -153.86 163.93 39.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 312' ' ' VAL . 18.8 t -54.85 -34.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.423 ' HB1' ' ND2' ' A' ' 308' ' ' ASN . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 309' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.452 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.6 32.71 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -111.62 81.79 3.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -12.51 33.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.703 2.269 . . . . 0.0 112.314 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -173.57 160.61 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' HA ' ' NH1' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -139.05 116.52 11.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -59.23 139.57 56.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -105.59 87.0 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -91.24 138.68 31.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.26 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.0 m -105.81 101.08 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.883 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.4 t -104.61 -44.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -86.68 101.82 2.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 90.7 p -120.28 -57.91 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.901 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.1 p -108.48 81.6 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 39.37 69.53 0.41 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -121.46 -52.4 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 265' ' ' GLY . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 264' ' ' ILE . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.516 ' CE1' ' HE3' ' A' ' 276' ' ' MET . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.401 HD11 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.405 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 296' ' ' HIS . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.472 ' CB ' ' HD2' ' A' ' 301' ' ' ARG . 77.5 mt -122.29 -55.05 1.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ARG . . . . . 0.472 ' HD2' ' CB ' ' A' ' 300' ' ' LEU . 0.0 OUTLIER -152.77 149.53 28.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 303' ' ' GLU . 1.0 OUTLIER -45.87 166.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 304' ' ' GLY . 16.5 mt-10 -35.02 -69.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 303' ' ' GLU . . . 34.44 -107.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -172.97 120.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 86.5 t -146.41 130.5 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -57.88 -74.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 308' ' ' ASN . 0.0 OUTLIER -159.33 -179.85 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 276' ' ' MET . 4.0 t -57.82 -41.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB2' ' CD1' ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.424 ' C ' HG21 ' A' ' 338' ' ' VAL . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.13 106.43 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.61 -34.63 34.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 1.0 OUTLIER -116.04 83.57 12.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.911 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.91 2.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.73 105.46 11.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -97.97 174.14 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -146.9 130.85 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -123.46 146.54 47.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.08 156.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.07 -51.29 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.847 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 324' ' ' LEU . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.819 ' CE1' HD13 ' A' ' 294' ' ' LEU . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.819 HD13 ' CE1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.505 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.505 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.688 HD13 HG11 ' A' ' 312' ' ' VAL . 84.2 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 313' ' ' VAL . 21.8 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.817 0.342 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.688 HG11 HD13 ' A' ' 300' ' ' LEU . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 312' ' ' VAL . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 262' ' ' PRO . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 264' ' ' ILE . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 330' ' ' LYS . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LYS . . . . . 0.571 ' HB2' HG23 ' A' ' 327' ' ' THR . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 333' ' ' LEU . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 332' ' ' SER . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 324' ' ' LEU . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.506 ' HG2' HG12 ' A' ' 321' ' ' VAL . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 345' ' ' ASP . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.409 ' N ' HG22 ' A' ' 267' ' ' ILE . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.634 ' NZ ' HG22 ' A' ' 273' ' ' THR . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' THR . . . . . 0.634 HG22 ' NZ ' ' A' ' 271' ' ' LYS . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 294' ' ' LEU . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 291' ' ' TRP . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.589 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 290' ' ' ARG . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.589 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.456 ' C ' ' CD ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 299' ' ' GLU . 60.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.715 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.705 HG12 HG13 ' A' ' 313' ' ' VAL . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 309' ' ' VAL . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LYS . . . . . 0.495 ' HB3' HG11 ' A' ' 338' ' ' VAL . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 320' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.572 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.8 t70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.448 ' HB2' HG21 ' A' ' 323' ' ' VAL . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 324' ' ' LEU . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.593 HG11 HD11 ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 291' ' ' TRP . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.44 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 284' ' ' LEU . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.437 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 313' ' ' VAL . 61.2 t . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.61 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 313' ' ' VAL . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.471 ' CD ' ' H ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.428 ' C ' HG21 ' A' ' 338' ' ' VAL . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 262' ' ' PRO . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 264' ' ' ILE . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 327' ' ' THR . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 327' ' ' THR . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.425 ' HG2' HG12 ' A' ' 321' ' ' VAL . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.648 HD21 HD22 ' A' ' 333' ' ' LEU . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.554 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.612 ' HB3' HG11 ' A' ' 312' ' ' VAL . 42.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 300' ' ' LEU . 39.1 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.861 0.362 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 300' ' ' LEU . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 319' ' ' VAL . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 318' ' ' ARG . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.663 HG12 ' HG2' ' A' ' 335' ' ' MET . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 334' ' ' SER . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 327' ' ' THR . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.648 HD22 HD21 ' A' ' 284' ' ' LEU . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 324' ' ' LEU . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.663 ' HG2' HG12 ' A' ' 321' ' ' VAL . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.656 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.4 ' CB ' HG21 ' A' ' 313' ' ' VAL . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.506 ' CE1' HD13 ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 291' ' ' TRP . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.557 ' HB2' HD12 ' A' ' 284' ' ' LEU . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.506 HD13 ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.459 ' CE1' HG22 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.459 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 299' ' ' GLU . 80.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 275' ' ' ILE . 75.7 t . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.861 0.363 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 309' ' ' VAL . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 309' ' ' VAL . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 264' ' ' ILE . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 284' ' ' LEU . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 324' ' ' LEU . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 267' ' ' ILE . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.41 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 278' ' ' PHE . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.564 ' O ' HD23 ' A' ' 300' ' ' LEU . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.648 ' HB3' HG11 ' A' ' 312' ' ' VAL . 66.2 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 313' ' ' VAL . 47.3 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 300' ' ' LEU . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 275' ' ' ILE . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 338' ' ' VAL . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 334' ' ' SER . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 327' ' ' THR . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 324' ' ' LEU . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 322' ' ' LYS . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 324' ' ' LEU . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.492 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.492 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.529 ' CE1' HG22 ' A' ' 297' ' ' ILE . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 296' ' ' HIS . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 312' ' ' VAL . 15.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 313' ' ' VAL . 41.4 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.856 0.36 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.46 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 313' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.625 HG22 HG12 ' A' ' 309' ' ' VAL . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 264' ' ' ILE . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 321' ' ' VAL . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.9 t0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 345' ' ' ASP . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 313' ' ' VAL . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' ' 309' ' ' VAL . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 262' ' ' PRO . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.496 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 299' ' ' GLU . 43.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 313' ' ' VAL . 3.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.877 0.37 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 313' ' ' VAL . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 312' ' ' VAL . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.487 ' HG2' HG13 ' A' ' 319' ' ' VAL . 6.6 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 317' ' ' GLN . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.6 ' N ' HG21 ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 334' ' ' SER . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 327' ' ' THR . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 329' ' ' THR . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.429 ' CG ' HG12 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.6 HG21 ' N ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 267' ' ' ILE . 4.1 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 291' ' ' TRP . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.752 ' HB2' HD12 ' A' ' 284' ' ' LEU . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 281' ' ' PHE . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 299' ' ' GLU . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.401 ' HB2' HG12 ' A' ' 295' ' ' VAL . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.913 HD13 HG11 ' A' ' 312' ' ' VAL . 80.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 300' ' ' LEU . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 312' ' ' VAL . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LYS . . . . . 0.449 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.748 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 329' ' ' THR . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 321' ' ' VAL . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.748 ' HG2' HG12 ' A' ' 321' ' ' VAL . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 341' ' ' GLU . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.449 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 324' ' ' LEU . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 345' ' ' ASP . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 275' ' ' ILE . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.466 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.447 ' N ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 291' ' ' TRP . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.438 ' HB2' HD12 ' A' ' 284' ' ' LEU . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 312' ' ' VAL . 62.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 313' ' ' VAL . 21.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.86 0.362 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 313' ' ' VAL . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 309' ' ' VAL . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 335' ' ' MET . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 264' ' ' ILE . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 333' ' ' LEU . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 332' ' ' SER . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 321' ' ' VAL . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.5 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' A' ' 287' ' ' LEU . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.569 ' HB3' HG11 ' A' ' 309' ' ' VAL . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.422 ' CG ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 262' ' ' PRO . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.524 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.446 ' O ' HD23 ' A' ' 300' ' ' LEU . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 299' ' ' GLU . 76.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 280' ' ' CYS . 43.4 t . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.859 0.361 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 313' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 312' ' ' VAL . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.449 ' C ' HG21 ' A' ' 338' ' ' VAL . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 334' ' ' SER . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 327' ' ' THR . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.41 ' O ' HD23 ' A' ' 333' ' ' LEU . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 332' ' ' SER . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.653 ' HB3' HD21 ' A' ' 324' ' ' LEU . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.505 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.62 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 291' ' ' TRP . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' HB2' HD12 ' A' ' 284' ' ' LEU . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 296' ' ' HIS . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 309' ' ' VAL . 57.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 313' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 313' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 309' ' ' VAL . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 333' ' ' LEU . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 329' ' ' THR . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 333' ' ' LEU . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 332' ' ' SER . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.625 ' HB2' HD11 ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 337' ' ' ASP . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.662 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 309' ' ' VAL . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 291' ' ' TRP . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.585 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 284' ' ' LEU . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.464 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 275' ' ' ILE . 92.0 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.82 0.343 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 275' ' ' ILE . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 262' ' ' PRO . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 334' ' ' SER . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 327' ' ' THR . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 327' ' ' THR . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.763 ' HB3' HD11 ' A' ' 324' ' ' LEU . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 345' ' ' ASP . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 291' ' ' TRP . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.682 HG23 HD12 ' A' ' 297' ' ' ILE . 95.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 309' ' ' VAL . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 309' ' ' VAL . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LYS . . . . . 0.664 ' C ' HG11 ' A' ' 338' ' ' VAL . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 334' ' ' SER . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 324' ' ' LEU . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.487 ' HG2' HG12 ' A' ' 321' ' ' VAL . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.664 HG11 ' C ' ' A' ' 320' ' ' LYS . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.555 ' HA ' HD11 ' A' ' 267' ' ' ILE . 7.8 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' A' ' 261' ' ' GLU . 7.2 pt-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.584 ' HD3' HD13 ' A' ' 287' ' ' LEU . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 275' ' ' ILE . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 294' ' ' LEU . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.584 HD13 ' HD3' ' A' ' 262' ' ' PRO . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.842 ' HB2' HD12 ' A' ' 284' ' ' LEU . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 297' ' ' ILE . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.642 HD13 HG11 ' A' ' 312' ' ' VAL . 39.2 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.669 HG12 HG22 ' A' ' 313' ' ' VAL . 26.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.838 0.351 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.642 HG11 HD13 ' A' ' 300' ' ' LEU . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 309' ' ' VAL . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 333' ' ' LEU . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 333' ' ' LEU . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 321' ' ' VAL . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.685 ' HB2' HD11 ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.502 HG21 ' C ' ' A' ' 321' ' ' VAL . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.439 ' CG ' ' HG2' ' A' ' 341' ' ' GLU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.403 HG21 ' OE1' ' A' ' 344' ' ' GLU . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.403 ' OE1' HG21 ' A' ' 342' ' ' THR . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.555 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.54 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.427 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.79 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.79 HG22 HG12 ' A' ' 309' ' ' VAL . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 275' ' ' ILE . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . 0.491 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LYS . . . . . 0.429 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 333' ' ' LEU . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 262' ' ' PRO . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 321' ' ' VAL . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 343' ' ' GLY . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 342' ' ' THR . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 345' ' ' ASP . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.464 ' HD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.406 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 271' ' ' LYS . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.423 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 312' ' ' VAL . 72.4 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 300' ' ' LEU . 59.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 300' ' ' LEU . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 312' ' ' VAL . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.464 HG23 ' HD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 334' ' ' SER . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' ' 324' ' ' LEU . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 343' ' ' GLY . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 282' ' ' VAL . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.542 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 294' ' ' LEU . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 271' ' ' LYS . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.415 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 313' ' ' VAL . 48.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.84 0.352 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.574 HG22 HG12 ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LYS . . . . . 0.47 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.566 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 334' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.566 ' HG2' HG12 ' A' ' 321' ' ' VAL . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.47 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PRO . . . . . 0.466 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 275' ' ' ILE . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 272' ' ' VAL . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 309' ' ' VAL . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 294' ' ' LEU . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 291' ' ' TRP . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.466 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.547 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 312' ' ' VAL . 40.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 313' ' ' VAL . 18.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.69 HG12 HG13 ' A' ' 313' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 309' ' ' VAL . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.474 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 327' ' ' THR . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' LYS . . . . . 0.418 ' HB3' HG23 ' A' ' 327' ' ' THR . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.538 ' HG2' HG12 ' A' ' 321' ' ' VAL . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 343' ' ' GLY . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 323' ' ' VAL . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 275' ' ' ILE . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 309' ' ' VAL . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.624 ' HB3' HG11 ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 294' ' ' LEU . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 291' ' ' TRP . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 284' ' ' LEU . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLU . . . . . 0.42 ' C ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 1.041 HD13 HG11 ' A' ' 312' ' ' VAL . 77.5 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 313' ' ' VAL . 4.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.834 0.35 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.041 HG11 HD13 ' A' ' 300' ' ' LEU . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 333' ' ' LEU . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.454 HG23 ' HD1' ' A' ' 268' ' ' TYR . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 327' ' ' THR . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 321' ' ' VAL . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' MET . . . . . 0.412 ' CG ' HG12 ' A' ' 321' ' ' VAL . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 299' ' ' GLU . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -85.78 96.67 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 67.8 m -161.66 133.1 5.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.34 -111.38 2.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.0 m 59.21 42.78 18.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.1 p -53.06 138.73 30.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -153.08 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.467 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 -47.74 -42.8 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 324' ' ' LEU . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.819 ' CE1' HD13 ' A' ' 294' ' ' LEU . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.819 HD13 ' CE1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.505 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.505 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.688 HD13 HG11 ' A' ' 312' ' ' VAL . 84.2 mt -130.61 -50.1 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.511 ' HD3' HG22 ' A' ' 306' ' ' VAL . 67.6 mtp180 -123.9 172.06 9.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 304' ' ' GLY . 7.3 tpt180 -75.5 159.36 31.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -38.64 95.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 302' ' ' ARG . . . -165.13 -144.24 3.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -118.44 115.02 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.511 HG22 ' HD3' ' A' ' 301' ' ' ARG . 62.0 t -99.37 129.61 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.47 -70.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.605 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.3 OUTLIER -151.17 154.93 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.915 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 313' ' ' VAL . 21.8 t -74.31 -30.54 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.688 HG11 HD13 ' A' ' 300' ' ' LEU . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 312' ' ' VAL . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 262' ' ' PRO . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 264' ' ' ILE . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 330' ' ' LYS . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.571 ' HB2' HG23 ' A' ' 327' ' ' THR . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 333' ' ' LEU . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 332' ' ' SER . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 324' ' ' LEU . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.506 ' HG2' HG12 ' A' ' 321' ' ' VAL . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.92 105.18 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.29 32.57 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -123.45 80.74 53.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.627 0.727 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.48 12.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.93 139.82 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -164.97 150.07 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -133.25 141.26 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 164.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.08 -52.05 2.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.09 150.63 30.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.88 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 53.5 p -107.31 109.65 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -132.78 -52.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 129.54 -157.77 21.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.1 p -96.26 87.12 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 84.3 p -143.86 113.96 7.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -115.1 46.14 1.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -99.89 -42.56 6.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 345' ' ' ASP . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.409 ' N ' HG22 ' A' ' 267' ' ' ILE . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.634 ' NZ ' HG22 ' A' ' 273' ' ' THR . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' THR . . . . . 0.634 HG22 ' NZ ' ' A' ' 271' ' ' LYS . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 294' ' ' LEU . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 291' ' ' TRP . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.589 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 290' ' ' ARG . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.589 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.456 ' C ' ' CD ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 306' ' ' VAL . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 299' ' ' GLU . 60.1 mt -130.77 -67.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.805 ' HG2' HG21 ' A' ' 306' ' ' VAL . 7.6 ptt180 -122.19 162.46 21.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -40.46 137.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -44.56 100.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.24 -132.31 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -119.7 69.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 301' ' ' ARG . 93.0 t -96.03 136.25 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.24 -57.13 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.708 ' OD1' ' HB3' ' A' ' 310' ' ' ALA . 10.5 t-20 -97.55 157.34 16.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.715 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t -108.01 -15.5 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 308' ' ' ASN . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.705 HG12 HG13 ' A' ' 313' ' ' VAL . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 309' ' ' VAL . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.495 ' HB3' HG11 ' A' ' 338' ' ' VAL . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' O ' HD12 ' A' ' 346' ' ' LEU . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 320' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.572 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.8 t70 -92.8 97.18 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 337' ' ' ASP . 14.1 mt -88.64 39.81 0.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 322' ' ' LYS . 1.2 t30 -107.93 76.85 0.61 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -45.42 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.374 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.2 m120 -130.15 -35.99 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 349' ' ' ASN . 10.0 tpp180 -34.53 106.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -158.35 160.2 36.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.827 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -140.68 146.6 38.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -65.99 127.98 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.18 -53.84 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.7 m -108.36 90.07 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 m -66.41 102.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 54.23 -138.41 39.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.5 p -48.32 -52.23 22.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.0 m 48.18 41.24 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.81 84.05 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.23 -46.57 86.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.448 ' HB2' HG21 ' A' ' 323' ' ' VAL . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.449 HD13 HD13 ' A' ' 354' ' ' LEU . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.593 HG11 HD11 ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 291' ' ' TRP . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.44 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 284' ' ' LEU . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.437 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt -134.21 -68.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -103.85 114.55 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 33.6 ptt85 -71.31 -38.56 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 7.0 tp10 -130.49 107.07 8.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 143.5 159.88 8.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 36.9 mtp85 -94.22 119.04 32.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.861 0.362 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.61 ' HB ' HD11 ' A' ' 297' ' ' ILE . 44.4 t -119.61 137.25 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.44 -33.49 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -127.58 177.93 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 313' ' ' VAL . 61.2 t -117.8 -28.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.61 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 313' ' ' VAL . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.471 ' CD ' ' H ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.428 ' C ' HG21 ' A' ' 338' ' ' VAL . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 262' ' ' PRO . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 264' ' ' ILE . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 327' ' ' THR . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 327' ' ' THR . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.425 ' HG2' HG12 ' A' ' 321' ' ' VAL . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 346' ' ' LEU . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.35 96.19 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 339' ' ' ASP . 26.4 mt -92.74 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -130.42 74.41 80.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.23 5.93 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -105.56 63.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -138.48 108.01 6.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -107.49 -61.47 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.13 105.04 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -132.99 152.25 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 264' ' ' ILE . 6.6 mp -85.46 -49.94 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -82.16 -55.07 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.6 p -126.66 119.09 26.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -44.06 167.02 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.476 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.4 t -125.94 84.55 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.1 t -134.19 138.52 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -177.34 -54.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.98 -47.84 5.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.648 HD21 HD22 ' A' ' 333' ' ' LEU . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.554 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.548 HD11 ' CG1' ' A' ' 306' ' ' VAL . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.612 ' HB3' HG11 ' A' ' 312' ' ' VAL . 42.5 mt -128.15 -63.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 306' ' ' VAL . 1.0 OUTLIER -79.43 123.91 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -70.68 -42.12 71.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -144.34 127.48 16.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 117.21 -174.87 15.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.77 137.13 35.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 301' ' ' ARG . 41.2 t -90.22 144.71 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -100.28 -66.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 312' ' ' VAL . 3.8 t-20 -155.96 135.94 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 300' ' ' LEU . 39.1 t -53.41 -36.62 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 308' ' ' ASN . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 319' ' ' VAL . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 318' ' ' ARG . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.663 HG12 ' HG2' ' A' ' 335' ' ' MET . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 334' ' ' SER . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 327' ' ' THR . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.648 HD22 HD21 ' A' ' 284' ' ' LEU . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 324' ' ' LEU . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.663 ' HG2' HG12 ' A' ' 321' ' ' VAL . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.54 108.57 7.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.57 34.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -125.14 80.91 63.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.681 0.753 . . . . 0.0 110.876 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -29.48 23.68 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.324 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -170.06 120.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -101.98 150.81 22.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.77 -66.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 354' ' ' LEU . 3.3 tpm_? -167.88 137.68 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.9 t-20 -54.32 83.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 354' ' ' LEU . 6.9 tt -57.87 118.76 5.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 353' ' ' ASN . 90.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 54.7 p -47.92 149.59 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.4 t -137.13 112.0 8.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 80.85 -87.69 1.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t 44.96 41.93 5.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 33.0 m -135.21 159.32 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.05 44.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -102.77 -46.53 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.656 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.4 ' CB ' HG21 ' A' ' 313' ' ' VAL . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.506 ' CE1' HD13 ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 291' ' ' TRP . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.557 ' HB2' HD12 ' A' ' 284' ' ' LEU . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.506 HD13 ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.459 ' CE1' HG22 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.697 HD11 ' CG1' ' A' ' 306' ' ' VAL . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 299' ' ' GLU . 80.0 mt -131.78 -56.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.535 ' HB2' HG22 ' A' ' 306' ' ' VAL . 26.7 mtm180 -129.83 148.21 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -102.87 -68.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -81.93 110.85 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.868 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 120.34 128.93 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -68.25 92.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.697 ' CG1' HD11 ' A' ' 297' ' ' ILE . 21.2 t -43.84 150.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 312' ' ' VAL . 67.0 t30 -150.92 129.54 12.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 275' ' ' ILE . 75.7 t -34.22 -50.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 308' ' ' ASN . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 309' ' ' VAL . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 264' ' ' ILE . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 284' ' ' LEU . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 324' ' ' LEU . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.72 119.11 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.21 23.21 11.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -119.63 80.72 23.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.923 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 349' ' ' ASN . 53.9 Cg_endo -69.77 -21.85 32.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 348' ' ' PRO . 9.2 m120 -161.82 130.64 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -149.05 148.52 29.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -74.2 116.05 14.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -106.64 110.46 22.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -107.64 115.43 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 26.8 tp -146.89 131.4 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.4 m -98.66 143.42 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.5 p -40.52 121.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.72 94.64 2.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.7 t -74.02 133.54 42.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 m -91.96 -58.58 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.826 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 84.56 -53.84 4.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -76.58 -57.83 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 267' ' ' ILE . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.41 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 278' ' ' PHE . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.564 ' O ' HD23 ' A' ' 300' ' ' LEU . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.648 ' HB3' HG11 ' A' ' 312' ' ' VAL . 66.2 mt -133.7 -64.75 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.69 ' HB2' HG22 ' A' ' 306' ' ' VAL . 2.1 tpm_? -74.99 161.42 29.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -35.64 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.78 -43.7 62.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 306' ' ' VAL . . . 145.82 -78.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -47.49 140.42 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 301' ' ' ARG . 60.2 t -137.92 138.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.12 -69.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.788 ' O ' HG23 ' A' ' 312' ' ' VAL . 27.6 p-10 -160.05 139.69 11.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 313' ' ' VAL . 47.3 t -58.23 -41.58 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 308' ' ' ASN . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 275' ' ' ILE . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 338' ' ' VAL . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 334' ' ' SER . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 327' ' ' THR . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 324' ' ' LEU . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 322' ' ' LYS . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.45 98.4 9.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.22 39.3 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -132.34 84.33 52.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.636 0.732 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -44.41 2.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.37 144.01 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.6 ttp85 -140.08 118.18 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -82.97 111.15 18.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.05 100.49 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -124.79 158.67 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.15 122.39 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 62.6 m -86.44 -53.42 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.895 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.6 t -123.72 -59.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 85.85 -178.15 49.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.5 t -102.68 103.13 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.0 m -50.34 -47.64 55.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.49 45.99 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -102.49 -53.85 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 324' ' ' LEU . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.492 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.492 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.529 ' CE1' HG22 ' A' ' 297' ' ' ILE . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.693 HD11 ' O ' ' A' ' 306' ' ' VAL . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.745 HD12 HG11 ' A' ' 306' ' ' VAL . 15.9 mt -119.73 -49.6 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.465 ' HD3' HG22 ' A' ' 306' ' ' VAL . 61.6 mtp85 -132.39 174.72 9.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -121.16 -52.59 2.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -84.51 -75.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -52.58 140.63 29.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -71.76 157.43 37.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 300' ' ' LEU . 57.4 t -128.85 98.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.16 -46.99 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -176.08 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 313' ' ' VAL . 41.4 t -121.25 -32.12 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.46 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 313' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.625 HG22 HG12 ' A' ' 309' ' ' VAL . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 264' ' ' ILE . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 321' ' ' VAL . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 346' ' ' LEU . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.448 ' CG ' HD21 ' A' ' 346' ' ' LEU . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.88 103.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 337' ' ' ASP . 52.5 mt -76.86 -37.63 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.26 81.59 3.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.605 0.717 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -17.62 37.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 0.0 112.371 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -114.05 122.79 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -107.83 -60.56 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -98.56 146.58 25.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -98.0 113.84 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.52 -60.36 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 354' ' ' LEU . 3.6 pp -72.41 120.3 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.3 t -124.34 101.54 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 0.0 110.864 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.6 t -52.51 98.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 167.41 100.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -137.39 127.49 26.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 64.4 p -113.38 115.08 27.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.61 -38.91 1.68 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.65 -57.73 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 345' ' ' ASP . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 313' ' ' VAL . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' ' 309' ' ' VAL . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 262' ' ' PRO . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.496 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 299' ' ' GLU . 43.6 mt -133.71 -59.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.452 ' HB2' HG22 ' A' ' 306' ' ' VAL . 1.3 mpt_? -119.39 132.97 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -51.63 169.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -40.63 120.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 173.57 -130.81 1.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -129.9 105.53 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 301' ' ' ARG . 48.5 t -104.77 140.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -90.39 -68.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 312' ' ' VAL . 18.8 p-10 -158.02 169.93 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 313' ' ' VAL . 3.0 t -76.21 -29.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.733 ' HB3' HD21 ' A' ' 308' ' ' ASN . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 308' ' ' ASN . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 312' ' ' VAL . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.487 ' HG2' HG13 ' A' ' 319' ' ' VAL . 6.6 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 317' ' ' GLN . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.6 ' N ' HG21 ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 334' ' ' SER . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 327' ' ' THR . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 329' ' ' THR . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.429 ' CG ' HG12 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 346' ' ' LEU . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.6 HG21 ' N ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 267' ' ' ILE . 4.1 t70 -93.11 104.87 17.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 337' ' ' ASP . 43.6 mt -79.24 -32.73 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 348' ' ' PRO . 64.3 t30 -127.87 87.99 54.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 347' ' ' ASN . 53.4 Cg_endo -69.78 1.28 4.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.307 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -157.37 113.07 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 160.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -74.9 -43.94 51.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -75.1 -50.83 15.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -41.18 134.76 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.91 -59.38 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.15 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 35.2 t -72.18 129.57 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 99.9 p -99.64 176.67 5.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -40.21 -73.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.6 m -113.97 169.93 8.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.6 m -150.43 121.92 7.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -176.5 66.89 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.75 -55.88 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 291' ' ' TRP . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.752 ' HB2' HD12 ' A' ' 284' ' ' LEU . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 281' ' ' PHE . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 299' ' ' GLU . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.401 ' HB2' HG12 ' A' ' 295' ' ' VAL . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.913 HD13 HG11 ' A' ' 312' ' ' VAL . 80.5 mt -123.84 -49.67 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 306' ' ' VAL . 61.7 mtt180 -139.16 112.52 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -51.76 -48.34 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.38 -48.31 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -39.32 111.3 0.19 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -55.3 104.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 301' ' ' ARG . 99.2 t -78.81 112.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -75.02 -63.62 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 312' ' ' VAL . 50.2 t30 -150.0 128.4 12.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t -43.92 -43.54 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 300' ' ' LEU . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 312' ' ' VAL . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.449 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.748 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 329' ' ' THR . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 321' ' ' VAL . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.748 ' HG2' HG12 ' A' ' 321' ' ' VAL . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 341' ' ' GLU . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.449 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -38.45 118.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 78.6 mt -98.05 -23.87 15.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -120.75 77.21 29.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -45.77 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.256 . . . . 0.0 112.389 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 350' ' ' ARG . 2.0 p-10 -39.34 -44.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 349' ' ' ASN . 27.2 ttt180 -34.98 -46.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -56.88 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -86.76 97.51 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -74.8 159.03 32.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 15.1 tp -171.34 131.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.151 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.4 t -48.16 103.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -109.91 41.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 124.75 -158.75 19.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.421 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.6 m -96.07 88.48 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -83.51 146.76 28.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 287' ' ' LEU . . . 157.98 -71.93 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.82 -43.45 69.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 324' ' ' LEU . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 345' ' ' ASP . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 275' ' ' ILE . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.466 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.447 ' N ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 291' ' ' TRP . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 259' ' ' GLY . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.438 ' HB2' HD12 ' A' ' 284' ' ' LEU . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 312' ' ' VAL . 62.8 mt -128.39 -33.61 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.416 ' NH1' ' HA ' ' A' ' 305' ' ' ARG . 15.8 ptt85 -124.01 122.75 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -62.76 -56.49 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.72 139.32 29.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 132.37 -134.23 7.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ARG . . . . . 0.416 ' HA ' ' NH1' ' A' ' 301' ' ' ARG . 20.0 ttm-85 -171.06 127.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 312' ' ' VAL . 86.7 t -121.2 148.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.7 OUTLIER -156.85 163.52 39.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 313' ' ' VAL . 21.4 t -55.87 -33.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 313' ' ' VAL . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 309' ' ' VAL . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 335' ' ' MET . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 264' ' ' ILE . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 333' ' ' LEU . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 332' ' ' SER . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 321' ' ' VAL . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.5 t0 -89.97 105.62 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.5 36.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -126.58 81.08 68.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.0 6.95 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.714 2.276 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -141.07 105.33 4.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 351' ' ' ARG . 23.9 ttp180 -93.48 -61.91 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 350' ' ' ARG . 7.2 tpp85 -34.5 99.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.09 85.74 7.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.71 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 354' ' ' LEU . 0.8 OUTLIER -44.89 117.86 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.9 p -97.28 97.34 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.0 p -164.65 141.77 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 67.77 121.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.1 m -136.65 140.26 42.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.7 t -54.37 156.88 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 164.88 -41.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -75.64 -58.63 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' A' ' 287' ' ' LEU . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.569 ' HB3' HG11 ' A' ' 309' ' ' VAL . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.422 ' CG ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 262' ' ' PRO . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.524 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.446 ' O ' HD23 ' A' ' 300' ' ' LEU . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 299' ' ' GLU . 76.5 mt -134.49 -65.21 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 306' ' ' VAL . 16.9 ttp180 -102.49 162.12 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -93.78 -42.9 8.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -44.31 169.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -42.82 -94.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -104.32 153.92 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 301' ' ' ARG . 22.5 t -104.13 150.24 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.81 -68.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.656 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.4 t30 -158.86 146.97 18.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 280' ' ' CYS . 43.4 t -64.36 -41.46 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 313' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 312' ' ' VAL . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.449 ' C ' HG21 ' A' ' 338' ' ' VAL . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 334' ' ' SER . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 327' ' ' THR . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.41 ' O ' HD23 ' A' ' 333' ' ' LEU . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 332' ' ' SER . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.653 ' HB3' HD21 ' A' ' 324' ' ' LEU . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 -89.81 99.12 12.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 347' ' ' ASN . 65.3 mt -88.44 -39.42 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 346' ' ' LEU . 0.8 OUTLIER -29.34 93.34 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.4 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 0.0 112.331 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -163.71 123.39 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -79.47 -51.96 8.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.472 ' CG ' HD12 ' A' ' 354' ' ' LEU . 14.7 tpp85 -49.0 143.46 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ARG . . . . . 0.42 ' HD3' ' C ' ' A' ' 352' ' ' ARG . 0.9 OUTLIER -113.58 -33.52 5.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 354' ' ' LEU . 7.6 t30 -142.93 133.71 25.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 354' ' ' LEU . 0.0 OUTLIER -143.05 -179.15 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 m -98.96 167.57 10.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.5 t -63.67 99.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 153.63 90.31 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.1 t -58.32 168.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.4 p -97.55 -59.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.551 ' O ' HD22 ' A' ' 287' ' ' LEU . . . 115.24 -69.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.61 -49.23 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.505 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.62 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 291' ' ' TRP . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 259' ' ' GLY . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' HB2' HD12 ' A' ' 284' ' ' LEU . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 308' ' ' ASN . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 309' ' ' VAL . 57.7 mt -134.99 -40.76 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.437 ' C ' ' HD3' ' A' ' 336' ' ' LYS . 0.0 OUTLIER -126.17 136.21 52.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 12.4 ptt-85 -83.27 -38.11 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 8.2 tp10 -138.41 150.66 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.61 -161.99 19.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.53 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 305' ' ' ARG . 4.4 tmm_? -143.02 114.22 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.448 HG11 ' CG2' ' A' ' 312' ' ' VAL . 64.7 t -103.52 138.61 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.169 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -46.15 -70.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.544 ' HA ' HD12 ' A' ' 297' ' ' ILE . 5.7 t-20 -159.9 172.2 18.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 313' ' ' VAL . 13.0 t -53.23 -38.08 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 313' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 309' ' ' VAL . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 333' ' ' LEU . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 329' ' ' THR . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 333' ' ' LEU . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 332' ' ' SER . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.625 ' HB2' HD11 ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.437 ' HD3' ' C ' ' A' ' 301' ' ' ARG . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 347' ' ' ASN . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.67 98.74 11.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.81 -40.64 28.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 337' ' ' ASP . 35.4 t-20 -134.65 87.69 30.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -31.01 21.5 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -141.38 134.31 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' HG2' ' N ' ' A' ' 351' ' ' ARG . 0.0 OUTLIER -114.84 -28.94 6.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 350' ' ' ARG . 1.9 tmm_? -108.47 129.1 55.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -42.51 155.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -93.38 92.32 7.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.15 -60.62 2.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 34.4 t -96.52 122.32 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 p -112.32 -34.41 5.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 76.83 -140.57 25.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.5 p -107.69 175.39 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 59.7 m -124.08 -60.25 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 142.03 -40.39 1.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -87.95 -57.31 2.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.662 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 309' ' ' VAL . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 291' ' ' TRP . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.585 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 284' ' ' LEU . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.464 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt -132.17 -34.04 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.447 ' NH1' ' HB2' ' A' ' 301' ' ' ARG . 0.0 OUTLIER -123.55 177.18 5.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -107.19 -43.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -163.51 138.69 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 152.34 -140.19 7.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -149.74 105.92 3.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 t -141.18 137.82 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.27 41.34 3.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -159.79 173.99 15.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 275' ' ' ILE . 92.0 t -134.69 -36.29 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 275' ' ' ILE . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 262' ' ' PRO . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 334' ' ' SER . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 327' ' ' THR . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 327' ' ' THR . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.763 ' HB3' HD11 ' A' ' 324' ' ' LEU . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 346' ' ' LEU . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.91 102.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 336' ' ' LYS . 85.3 mt -73.94 -36.05 64.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.14 81.31 1.25 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.639 0.733 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -43.12 2.81 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.335 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -92.05 103.26 15.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 ttt-85 -123.49 94.47 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 12.2 mtm105 -119.32 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -60.0 -42.66 94.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -162.08 154.24 19.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 355' ' ' VAL . 19.3 tp -108.73 107.47 17.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 355' ' ' VAL . 14.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.104 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 38.7 p -61.66 126.14 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.6 t -102.92 129.08 49.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 146.99 -177.22 25.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 67.5 m -95.3 116.67 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.7 t -130.03 91.7 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.45 59.42 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER -109.62 -54.39 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 345' ' ' ASP . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 291' ' ' TRP . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.1 -63.15 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -98.97 125.68 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -82.87 -34.54 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -39.66 -52.18 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 306' ' ' VAL . . . 148.89 -126.84 2.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -42.72 128.41 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.65 HG12 HD11 ' A' ' 297' ' ' ILE . 82.0 t -121.21 138.28 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -62.39 -72.28 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.115 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.733 ' O ' HG23 ' A' ' 312' ' ' VAL . 19.3 t30 -157.89 138.6 13.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.682 HG23 HD12 ' A' ' 297' ' ' ILE . 95.6 t -52.02 -48.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 308' ' ' ASN . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 309' ' ' VAL . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.664 ' C ' HG11 ' A' ' 338' ' ' VAL . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 334' ' ' SER . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 324' ' ' LEU . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.487 ' HG2' HG12 ' A' ' 321' ' ' VAL . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.664 HG11 ' C ' ' A' ' 320' ' ' LYS . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.583 ' OD1' HD11 ' A' ' 346' ' ' LEU . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.555 ' HA ' HD11 ' A' ' 267' ' ' ILE . 7.8 t0 -79.66 86.31 5.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.583 HD11 ' OD1' ' A' ' 339' ' ' ASP . 8.7 mt -70.19 -34.44 72.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 346' ' ' LEU . 21.0 t-20 -29.16 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.583 0.706 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.6 Cg_endo -69.79 -37.62 8.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.239 . . . . 0.0 112.366 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -146.45 134.42 21.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 351' ' ' ARG . 5.9 tpt180 -114.39 -51.07 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -37.35 145.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.33 164.45 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.67 52.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.77 95.49 5.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 67.3 m 39.44 45.15 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.3 t -102.47 86.16 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 151.01 122.47 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.3 t -110.65 -53.25 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.8 t -99.62 123.33 43.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -129.55 166.5 21.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' A' ' 261' ' ' GLU . 7.2 pt-20 -108.85 -56.48 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.584 ' HD3' HD13 ' A' ' 287' ' ' LEU . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 275' ' ' ILE . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 294' ' ' LEU . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.584 HD13 ' HD3' ' A' ' 262' ' ' PRO . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.842 ' HB2' HD12 ' A' ' 284' ' ' LEU . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 297' ' ' ILE . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.642 HD13 HG11 ' A' ' 312' ' ' VAL . 39.2 mt -117.13 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.498 ' CG ' HG21 ' A' ' 306' ' ' VAL . 9.4 ptp180 -160.41 113.06 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -57.05 -42.37 80.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 303' ' ' GLU . 6.3 pt-20 -66.84 109.85 3.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 93.44 141.93 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -84.61 83.51 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CG ' ' A' ' 301' ' ' ARG . 37.0 t -62.01 154.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 306' ' ' VAL . . . -133.98 -52.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.688 ' OD1' ' HB3' ' A' ' 310' ' ' ALA . 8.9 t-20 -103.61 134.38 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.669 HG12 HG22 ' A' ' 313' ' ' VAL . 26.2 t -83.31 -25.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.688 ' HB3' ' OD1' ' A' ' 308' ' ' ASN . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 308' ' ' ASN . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 309' ' ' VAL . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 333' ' ' LEU . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 333' ' ' LEU . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 321' ' ' VAL . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.685 ' HB2' HD11 ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.502 HG21 ' C ' ' A' ' 321' ' ' VAL . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.439 ' CG ' ' HG2' ' A' ' 341' ' ' GLU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.403 HG21 ' OE1' ' A' ' 344' ' ' GLU . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.403 ' OE1' HG21 ' A' ' 342' ' ' THR . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.85 95.6 10.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.425 ' C ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 mt -83.39 20.07 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 12.7 t-20 -114.26 64.28 1.34 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.634 0.73 . . . . 0.0 110.912 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 346' ' ' LEU . 53.5 Cg_endo -69.8 -50.74 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -141.83 115.53 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 351' ' ' ARG . 49.5 ttp85 -98.61 49.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 350' ' ' ARG . 5.2 mpt_? -133.19 42.37 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -125.14 -50.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.61 144.17 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 25.5 mt -143.67 110.97 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.6 t -95.26 120.66 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 258' ' ' SER . 2.4 p -60.06 -35.63 75.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 38.87 66.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.4 t 71.14 47.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.409 ' CB ' ' HB2' ' A' ' 255' ' ' SER . 41.3 t -75.0 109.34 8.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -165.38 55.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -103.0 -58.82 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.555 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.54 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.439 HD11 ' CG1' ' A' ' 306' ' ' VAL . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.427 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt -133.34 -57.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -120.96 136.46 54.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -99.11 -64.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.438 ' C ' ' CD ' ' A' ' 303' ' ' GLU . 0.3 OUTLIER -96.82 104.66 16.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 137.12 -164.2 25.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -117.09 155.18 29.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 297' ' ' ILE . 72.7 t -121.92 127.85 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -90.01 -58.49 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.8 OUTLIER -159.7 137.35 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.896 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.79 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t -52.1 -39.52 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 308' ' ' ASN . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.79 HG22 HG12 ' A' ' 309' ' ' VAL . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 275' ' ' ILE . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . 0.491 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.429 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 333' ' ' LEU . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 262' ' ' PRO . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 321' ' ' VAL . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 343' ' ' GLY . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 342' ' ' THR . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.85 99.41 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.14 -38.55 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.82 84.96 9.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.63 0.729 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -34.87 13.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -131.42 101.33 5.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -84.76 179.0 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -133.76 127.21 32.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 48.2 ttm-85 -123.13 108.32 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -142.41 129.52 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.65 -56.89 3.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 44.4 t -73.8 118.45 16.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 m -69.72 166.86 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 130.0 -54.57 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 38.7 m 46.77 42.42 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.3 t -86.91 82.06 7.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.89 98.06 0.34 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.38 -52.57 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 345' ' ' ASP . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.464 ' HD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.406 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 271' ' ' LYS . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.423 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 312' ' ' VAL . 72.4 mt -127.25 -53.69 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -122.29 143.27 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -43.56 165.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -41.58 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -171.95 -135.72 2.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -135.38 123.72 23.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.32 143.99 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.18 -69.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.707 ' O ' HG23 ' A' ' 312' ' ' VAL . 1.1 p30 -155.51 151.81 28.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 300' ' ' LEU . 59.4 t -62.09 -42.84 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 308' ' ' ASN . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 312' ' ' VAL . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.464 HG23 ' HD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 334' ' ' SER . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' ' 324' ' ' LEU . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.626 ' C ' HD12 ' A' ' 346' ' ' LEU . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.802 ' CG ' HD21 ' A' ' 346' ' ' LEU . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER -83.71 93.39 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.802 HD21 ' CG ' ' A' ' 339' ' ' ASP . 38.0 mt -68.91 -32.53 72.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -114.54 81.8 7.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.65 0.738 . . . . 0.0 110.817 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -44.08 2.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -130.5 113.3 14.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -101.52 43.63 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.402 ' HD3' ' N ' ' A' ' 352' ' ' ARG . 2.4 tmt_? -114.79 133.41 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ARG . . . . . 0.402 ' N ' ' HD3' ' A' ' 351' ' ' ARG . 31.0 ptt85 -138.08 151.25 47.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -63.39 133.54 54.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.24 118.38 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.3 t -83.34 44.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.8 p -108.72 41.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.22 147.95 18.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 76.7 p -119.45 41.9 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -94.73 129.34 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 170.32 125.78 0.83 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.68 -55.54 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 282' ' ' VAL . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.542 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 294' ' ' LEU . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 271' ' ' LYS . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.415 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 306' ' ' VAL . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt -131.24 -46.25 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.443 ' HG3' HG22 ' A' ' 306' ' ' VAL . 31.0 mmm180 -118.65 138.91 52.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -84.9 -72.92 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.81 148.63 27.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.67 148.45 22.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.58 132.52 43.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 297' ' ' ILE . 60.8 t -98.77 140.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.9 -72.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 312' ' ' VAL . 3.3 t30 -155.86 149.86 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 313' ' ' VAL . 48.4 t -46.63 -43.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 308' ' ' ASN . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.574 HG22 HG12 ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.47 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.566 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 334' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.566 ' HG2' HG12 ' A' ' 321' ' ' VAL . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.465 ' O ' HD12 ' A' ' 346' ' ' LEU . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.628 ' OD1' HD11 ' A' ' 346' ' ' LEU . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.47 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 348' ' ' PRO . 1.4 t70 -95.58 92.8 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.628 HD11 ' OD1' ' A' ' 339' ' ' ASP . 29.6 mt -65.72 -30.76 71.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -127.79 84.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.49 ' N ' ' OD1' ' A' ' 345' ' ' ASP . 53.6 Cg_endo -69.72 -44.2 2.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.05 138.81 43.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -132.84 132.96 42.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -44.04 110.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 9.8 tpt85 -81.36 92.21 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -131.5 172.27 12.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.77 41.57 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 26.5 t -91.98 131.72 37.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.2 p -142.68 153.85 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -79.55 -112.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -99.58 86.22 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.1 t -85.12 128.12 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.841 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.43 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.67 -47.9 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.466 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 275' ' ' ILE . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 272' ' ' VAL . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 309' ' ' VAL . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 294' ' ' LEU . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 291' ' ' TRP . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.466 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.547 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 312' ' ' VAL . 40.7 mt -118.21 -50.16 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -93.93 161.21 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.58 -62.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.68 55.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -170.26 178.89 42.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -119.86 153.75 35.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 312' ' ' VAL . 20.4 t -145.65 136.28 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -51.21 -59.52 4.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' A' ' 310' ' ' ALA . 6.2 p30 -153.86 163.93 39.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 313' ' ' VAL . 18.8 t -54.85 -34.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 308' ' ' ASN . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.69 HG12 HG13 ' A' ' 313' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 309' ' ' VAL . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.474 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 327' ' ' THR . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' LYS . . . . . 0.418 ' HB3' HG23 ' A' ' 327' ' ' THR . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.538 ' HG2' HG12 ' A' ' 321' ' ' VAL . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.6 32.71 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -111.62 81.79 3.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -12.51 33.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.703 2.269 . . . . 0.0 112.314 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -173.57 160.61 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -139.05 116.52 11.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -59.23 139.57 56.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -105.59 87.0 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -91.24 138.68 31.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.26 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.0 m -105.81 101.08 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.883 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.4 t -104.61 -44.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -86.68 101.82 2.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 90.7 p -120.28 -57.91 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.901 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.1 p -108.48 81.6 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 39.37 69.53 0.41 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -121.46 -52.4 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 343' ' ' GLY . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 323' ' ' VAL . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 275' ' ' ILE . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 309' ' ' VAL . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.624 ' HB3' HG11 ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 294' ' ' LEU . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 291' ' ' TRP . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 284' ' ' LEU . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLU . . . . . 0.42 ' C ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 1.041 HD13 HG11 ' A' ' 312' ' ' VAL . 77.5 mt -122.29 -55.05 1.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -152.77 149.53 28.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 303' ' ' GLU . 1.0 OUTLIER -45.87 166.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 304' ' ' GLY . 16.5 mt-10 -35.02 -69.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 303' ' ' GLU . . . 34.44 -107.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -172.97 120.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' CG ' ' A' ' 301' ' ' ARG . 86.5 t -146.41 130.5 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -57.88 -74.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -159.33 -179.85 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 313' ' ' VAL . 4.0 t -57.82 -41.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.041 HG11 HD13 ' A' ' 300' ' ' LEU . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 333' ' ' LEU . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.454 HG23 ' HD1' ' A' ' 268' ' ' TYR . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 327' ' ' THR . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 321' ' ' VAL . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' MET . . . . . 0.412 ' CG ' HG12 ' A' ' 321' ' ' VAL . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 299' ' ' GLU . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.13 106.43 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.61 -34.63 34.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 1.0 OUTLIER -116.04 83.57 12.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.911 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.91 2.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.73 105.46 11.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.404 ' CA ' HD21 ' A' ' 347' ' ' ASN . 16.9 ptt85 -97.97 174.14 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -146.9 130.85 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -123.46 146.54 47.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.08 156.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.07 -51.29 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.847 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 324' ' ' LEU . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.819 ' CE1' HD13 ' A' ' 294' ' ' LEU . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 291' ' ' TRP . 44.9 tp60 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.819 HD13 ' CE1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.505 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.505 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.688 HD13 HG11 ' A' ' 312' ' ' VAL . 84.2 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 313' ' ' VAL . 21.8 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.817 0.342 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.688 HG11 HD13 ' A' ' 300' ' ' LEU . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 312' ' ' VAL . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 262' ' ' PRO . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 264' ' ' ILE . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 330' ' ' LYS . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . 0.571 ' HB2' HG23 ' A' ' 327' ' ' THR . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 333' ' ' LEU . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 332' ' ' SER . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 324' ' ' LEU . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.506 ' HG2' HG12 ' A' ' 321' ' ' VAL . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 345' ' ' ASP . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.409 ' N ' HG22 ' A' ' 267' ' ' ILE . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.634 ' NZ ' HG22 ' A' ' 273' ' ' THR . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . 0.634 HG22 ' NZ ' ' A' ' 271' ' ' LYS . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 294' ' ' LEU . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 291' ' ' TRP . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.589 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 290' ' ' ARG . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.589 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.456 ' C ' ' CD ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 299' ' ' GLU . 60.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.715 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.705 HG12 HG13 ' A' ' 313' ' ' VAL . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 309' ' ' VAL . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . 0.495 ' HB3' HG11 ' A' ' 338' ' ' VAL . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 320' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.572 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.8 t70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.448 ' HB2' HG21 ' A' ' 323' ' ' VAL . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 324' ' ' LEU . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.593 HG11 HD11 ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 291' ' ' TRP . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.44 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 284' ' ' LEU . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.437 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 313' ' ' VAL . 61.2 t . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.61 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 313' ' ' VAL . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.471 ' CD ' ' H ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.428 ' C ' HG21 ' A' ' 338' ' ' VAL . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 262' ' ' PRO . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 264' ' ' ILE . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 327' ' ' THR . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 327' ' ' THR . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.425 ' HG2' HG12 ' A' ' 321' ' ' VAL . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.648 HD21 HD22 ' A' ' 333' ' ' LEU . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.554 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.612 ' HB3' HG11 ' A' ' 312' ' ' VAL . 42.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 300' ' ' LEU . 39.1 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.861 0.362 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 300' ' ' LEU . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 319' ' ' VAL . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 318' ' ' ARG . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.663 HG12 ' HG2' ' A' ' 335' ' ' MET . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 334' ' ' SER . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 327' ' ' THR . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.648 HD22 HD21 ' A' ' 284' ' ' LEU . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 324' ' ' LEU . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.663 ' HG2' HG12 ' A' ' 321' ' ' VAL . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.656 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.4 ' CB ' HG21 ' A' ' 313' ' ' VAL . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.506 ' CE1' HD13 ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 291' ' ' TRP . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.557 ' HB2' HD12 ' A' ' 284' ' ' LEU . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.506 HD13 ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.459 ' CE1' HG22 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.459 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 299' ' ' GLU . 80.0 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 275' ' ' ILE . 75.7 t . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.861 0.363 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 309' ' ' VAL . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 309' ' ' VAL . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 264' ' ' ILE . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 284' ' ' LEU . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 324' ' ' LEU . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 267' ' ' ILE . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.41 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 278' ' ' PHE . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.564 ' O ' HD23 ' A' ' 300' ' ' LEU . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.648 ' HB3' HG11 ' A' ' 312' ' ' VAL . 66.2 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 313' ' ' VAL . 47.3 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 300' ' ' LEU . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 275' ' ' ILE . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 338' ' ' VAL . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 334' ' ' SER . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 327' ' ' THR . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 324' ' ' LEU . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 322' ' ' LYS . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 324' ' ' LEU . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.492 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.492 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.529 ' CE1' HG22 ' A' ' 297' ' ' ILE . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 296' ' ' HIS . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 312' ' ' VAL . 15.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 313' ' ' VAL . 41.4 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.856 0.36 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.46 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 313' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.625 HG22 HG12 ' A' ' 309' ' ' VAL . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 264' ' ' ILE . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 321' ' ' VAL . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.9 t0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 345' ' ' ASP . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 313' ' ' VAL . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' ' 309' ' ' VAL . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 262' ' ' PRO . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.496 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 299' ' ' GLU . 43.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 313' ' ' VAL . 3.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.877 0.37 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.632 HG12 HG13 ' A' ' 313' ' ' VAL . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 312' ' ' VAL . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.487 ' HG2' HG13 ' A' ' 319' ' ' VAL . 19.4 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 317' ' ' GLN . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.6 ' N ' HG21 ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 334' ' ' SER . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 327' ' ' THR . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 329' ' ' THR . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.429 ' CG ' HG12 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.6 HG21 ' N ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 267' ' ' ILE . 4.1 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 291' ' ' TRP . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.752 ' HB2' HD12 ' A' ' 284' ' ' LEU . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 281' ' ' PHE . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 299' ' ' GLU . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.401 ' HB2' HG12 ' A' ' 295' ' ' VAL . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.913 HD13 HG11 ' A' ' 312' ' ' VAL . 80.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 300' ' ' LEU . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 312' ' ' VAL . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . 0.449 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.748 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 329' ' ' THR . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 321' ' ' VAL . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.748 ' HG2' HG12 ' A' ' 321' ' ' VAL . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 341' ' ' GLU . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.449 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 324' ' ' LEU . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 345' ' ' ASP . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 275' ' ' ILE . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.466 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.447 ' N ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 291' ' ' TRP . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.438 ' HB2' HD12 ' A' ' 284' ' ' LEU . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 312' ' ' VAL . 62.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 313' ' ' VAL . 21.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.86 0.362 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 313' ' ' VAL . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 309' ' ' VAL . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 335' ' ' MET . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 264' ' ' ILE . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 333' ' ' LEU . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 332' ' ' SER . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 321' ' ' VAL . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.5 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' A' ' 287' ' ' LEU . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.569 ' HB3' HG11 ' A' ' 309' ' ' VAL . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.422 ' CG ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 262' ' ' PRO . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.524 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.446 ' O ' HD23 ' A' ' 300' ' ' LEU . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 299' ' ' GLU . 76.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 280' ' ' CYS . 43.4 t . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.859 0.361 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 313' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 312' ' ' VAL . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.449 ' C ' HG21 ' A' ' 338' ' ' VAL . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 334' ' ' SER . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 327' ' ' THR . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.41 ' O ' HD23 ' A' ' 333' ' ' LEU . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 332' ' ' SER . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.653 ' HB3' HD21 ' A' ' 324' ' ' LEU . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.505 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.62 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 291' ' ' TRP . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' HB2' HD12 ' A' ' 284' ' ' LEU . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.526 HG22 ' CE1' ' A' ' 296' ' ' HIS . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 309' ' ' VAL . 57.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 313' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 313' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 309' ' ' VAL . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.423 HE21 ' CG1' ' A' ' 319' ' ' VAL . 8.7 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.423 ' CG1' HE21 ' A' ' 317' ' ' GLN . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 333' ' ' LEU . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 329' ' ' THR . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 333' ' ' LEU . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 332' ' ' SER . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.625 ' HB2' HD11 ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 337' ' ' ASP . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 336' ' ' LYS . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.662 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 309' ' ' VAL . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 291' ' ' TRP . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.585 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 284' ' ' LEU . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.464 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 275' ' ' ILE . 92.0 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.82 0.343 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 275' ' ' ILE . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 262' ' ' PRO . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 334' ' ' SER . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 327' ' ' THR . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 327' ' ' THR . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.763 ' HB3' HD11 ' A' ' 324' ' ' LEU . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 345' ' ' ASP . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 291' ' ' TRP . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.682 HG23 HD12 ' A' ' 297' ' ' ILE . 95.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 309' ' ' VAL . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 309' ' ' VAL . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . 0.664 ' C ' HG11 ' A' ' 338' ' ' VAL . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 334' ' ' SER . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 324' ' ' LEU . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.487 ' HG2' HG12 ' A' ' 321' ' ' VAL . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.664 HG11 ' C ' ' A' ' 320' ' ' LYS . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.555 ' HA ' HD11 ' A' ' 267' ' ' ILE . 7.8 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' A' ' 261' ' ' GLU . 7.2 pt-20 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.584 ' HD3' HD13 ' A' ' 287' ' ' LEU . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 275' ' ' ILE . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 294' ' ' LEU . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.584 HD13 ' HD3' ' A' ' 262' ' ' PRO . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.842 ' HB2' HD12 ' A' ' 284' ' ' LEU . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 297' ' ' ILE . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.642 HD13 HG11 ' A' ' 312' ' ' VAL . 39.2 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.669 HG12 HG22 ' A' ' 313' ' ' VAL . 26.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.838 0.351 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.642 HG11 HD13 ' A' ' 300' ' ' LEU . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 309' ' ' VAL . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 333' ' ' LEU . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 333' ' ' LEU . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 321' ' ' VAL . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.685 ' HB2' HD11 ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.502 HG21 ' C ' ' A' ' 321' ' ' VAL . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.439 ' CG ' ' HG2' ' A' ' 341' ' ' GLU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.403 HG21 ' OE1' ' A' ' 344' ' ' GLU . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.403 ' OE1' HG21 ' A' ' 342' ' ' THR . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.555 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.54 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.427 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.79 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.79 HG22 HG12 ' A' ' 309' ' ' VAL . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 275' ' ' ILE . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . 0.491 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . 0.429 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 333' ' ' LEU . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 262' ' ' PRO . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 321' ' ' VAL . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 343' ' ' GLY . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 342' ' ' THR . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 345' ' ' ASP . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.464 ' HD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.406 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 271' ' ' LYS . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.423 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 312' ' ' VAL . 72.4 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 300' ' ' LEU . 59.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.814 0.34 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 309' ' ' VAL . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 300' ' ' LEU . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 312' ' ' VAL . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.464 HG23 ' HD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 334' ' ' SER . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' ' 324' ' ' LEU . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 343' ' ' GLY . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 282' ' ' VAL . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.542 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 294' ' ' LEU . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 271' ' ' LYS . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.415 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 313' ' ' VAL . 48.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.84 0.352 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.574 HG22 HG12 ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . 0.47 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.566 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 334' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.566 ' HG2' HG12 ' A' ' 321' ' ' VAL . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.47 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . 0.466 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 275' ' ' ILE . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 272' ' ' VAL . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 309' ' ' VAL . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 294' ' ' LEU . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 291' ' ' TRP . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.466 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.547 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 312' ' ' VAL . 40.7 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 313' ' ' VAL . 18.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.69 HG12 HG13 ' A' ' 313' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 309' ' ' VAL . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.474 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 327' ' ' THR . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . 0.418 ' HB3' HG23 ' A' ' 327' ' ' THR . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.538 ' HG2' HG12 ' A' ' 321' ' ' VAL . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 343' ' ' GLY . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 323' ' ' VAL . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 275' ' ' ILE . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 309' ' ' VAL . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.624 ' HB3' HG11 ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 294' ' ' LEU . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 291' ' ' TRP . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 284' ' ' LEU . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . 0.42 ' C ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 1.041 HD13 HG11 ' A' ' 312' ' ' VAL . 77.5 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 313' ' ' VAL . 4.0 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.834 0.35 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.041 HG11 HD13 ' A' ' 300' ' ' LEU . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 333' ' ' LEU . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.454 HG23 ' HD1' ' A' ' 268' ' ' TYR . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 327' ' ' THR . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 321' ' ' VAL . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' MET . . . . . 0.412 ' CG ' HG12 ' A' ' 321' ' ' VAL . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 299' ' ' GLU . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -85.78 96.67 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 67.8 m -161.66 133.1 5.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.34 -111.38 2.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.0 m 59.21 42.78 18.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.1 p -53.06 138.73 30.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -153.08 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.467 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 261' ' ' GLU . 11.5 pt-20 -47.74 -42.8 26.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 70.8 mt-10 -102.72 147.92 34.78 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.668 0.747 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 54.2 Cg_endo -69.75 155.72 65.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.683 2.255 . . . . 0.0 112.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 32.5 m -104.34 130.34 52.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 324' ' ' LEU . 62.1 mt -65.38 136.55 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.95 30.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.18 157.57 22.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.85 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.5 mt -105.43 142.8 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -138.89 162.09 35.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.18 142.27 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.68 -176.57 21.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -149.9 141.19 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 275' ' ' ILE . 20.6 t -70.96 125.91 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 53.0 p -106.7 -32.95 7.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -146.19 124.23 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 272' ' ' VAL . 3.4 mp -95.71 106.93 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.5 mmt -89.74 150.98 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -52.0 -25.29 8.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -96.34 -61.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.49 -159.0 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.7 p -143.73 134.04 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.819 ' CE1' HD13 ' A' ' 294' ' ' LEU . 33.8 m-85 -80.32 124.6 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.07 121.95 68.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 291' ' ' TRP . 44.9 tp60 -89.52 127.92 35.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 53.9 mt -75.25 150.71 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.68 164.33 15.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 88.47 -70.65 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 26.0 mt -41.25 143.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -67.21 -49.47 64.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -76.8 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -49.18 114.65 1.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.7 m95 -117.01 130.28 56.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -121.81 116.2 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.89 16.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.447 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.819 HD13 ' CE1' ' A' ' 281' ' ' PHE . 21.1 tp -126.56 141.59 51.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 5.8 t -110.2 109.98 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.082 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.505 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.0 t-80 -63.01 161.27 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.505 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.2 tt -59.57 -19.42 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 51.7 p -82.42 -14.34 55.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.36 42.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.688 HD13 HG11 ' A' ' 312' ' ' VAL . 84.2 mt -130.61 -50.1 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.511 ' HD3' HG22 ' A' ' 306' ' ' VAL . 67.6 mtp180 -123.9 172.06 9.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 304' ' ' GLY . 7.3 tpt180 -75.5 159.36 31.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -38.64 95.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 302' ' ' ARG . . . -165.13 -144.24 3.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -118.44 115.02 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.511 HG22 ' HD3' ' A' ' 301' ' ' ARG . 62.0 t -99.37 129.61 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -73.47 -70.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.605 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.3 OUTLIER -151.17 154.93 37.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.915 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 313' ' ' VAL . 21.8 t -74.31 -30.54 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -38.2 -60.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.21 -28.51 65.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.688 HG11 HD13 ' A' ' 300' ' ' LEU . 94.4 t -61.43 -43.68 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 312' ' ' VAL . 26.8 m -144.74 156.85 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 5.9 t -110.57 171.11 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -81.61 123.2 28.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.6 65.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.5 134.73 40.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -73.76 129.61 38.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.17 159.18 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -107.68 126.61 52.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.506 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.4 m -131.18 169.84 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.457 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 20.3 ttmt -124.34 144.33 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 262' ' ' PRO . 99.5 t -76.11 104.32 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 264' ' ' ILE . 65.7 mt -72.54 -60.48 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 10.3 t -155.39 143.87 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.456 ' C ' ' CD1' ' A' ' 326' ' ' PHE . 5.6 t80 -123.97 127.98 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 330' ' ' LYS . 5.0 t -149.6 111.32 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.27 -118.18 8.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 80.7 p -98.89 38.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.571 ' HB2' HG23 ' A' ' 327' ' ' THR . 50.5 mtpt -135.22 113.29 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.5 m -121.73 114.56 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 333' ' ' LEU . 74.2 m -91.74 152.7 20.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 332' ' ' SER . 50.5 mt -148.47 143.72 26.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 324' ' ' LEU . 1.8 m -119.95 141.12 49.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.506 ' HG2' HG12 ' A' ' 321' ' ' VAL . 77.8 mtp -105.12 -54.87 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 30.7 pttt -51.95 -33.48 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 2.9 m-20 -66.57 -34.95 79.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 61.3 t -100.85 107.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -47.54 130.11 13.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -83.48 39.92 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.97 -60.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 6.5 t -117.22 -12.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 82.97 29.62 33.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -76.14 155.81 34.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.92 105.18 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.29 32.57 0.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -123.45 80.74 53.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.627 0.727 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.48 12.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.93 139.82 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -164.97 150.07 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -133.25 141.26 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.68 164.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.08 -52.05 2.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.09 150.63 30.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.88 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 53.5 p -107.31 109.65 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -132.78 -52.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 129.54 -157.77 21.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.1 p -96.26 87.12 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 84.3 p -143.86 113.96 7.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -115.1 46.14 1.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -99.89 -42.56 6.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -111.84 148.97 40.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.67 0.748 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 168.85 20.45 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 86.5 m -117.88 133.36 56.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.83 135.97 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.184 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.88 -16.1 60.2 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.35 159.48 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 345' ' ' ASP . 65.1 mt -104.08 152.66 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.409 ' N ' HG22 ' A' ' 267' ' ' ILE . 90.6 m-85 -150.68 163.89 37.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -96.07 139.88 31.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.46 171.38 26.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.634 ' NZ ' HG22 ' A' ' 273' ' ' THR . 0.2 OUTLIER -138.6 137.84 37.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.834 0.35 . . . . 0.0 110.932 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.0 t -69.11 116.65 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . 0.634 HG22 ' NZ ' ' A' ' 271' ' ' LYS . 59.2 p -94.66 -31.74 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -153.0 139.03 18.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -108.16 117.29 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.11 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 14.3 mmt -100.02 153.31 19.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -54.67 -16.06 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.5 OUTLIER -105.56 -63.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -130.41 -174.98 13.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.04 134.2 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.672 ' CE1' HD13 ' A' ' 294' ' ' LEU . 10.7 m-85 -80.93 123.88 28.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.8 t -116.91 126.28 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.12 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.82 121.07 39.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 291' ' ' TRP . 58.2 mt -69.8 150.57 46.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -123.1 148.03 46.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 107.37 -74.12 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' GLY . 45.5 mt -35.39 145.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -61.88 -46.36 89.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.589 ' HE2' ' CZ2' ' A' ' 291' ' ' TRP . 6.6 ttpm? -93.28 103.17 15.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 290' ' ' ARG . 16.2 ttp-105 -51.09 132.11 27.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.589 ' CZ2' ' HE2' ' A' ' 289' ' ' LYS . 73.4 m95 -120.99 158.93 26.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.456 ' C ' ' CD ' ' A' ' 292' ' ' GLU . 0.3 OUTLIER -136.61 117.58 14.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 157.77 15.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.5 tp -112.64 139.79 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.915 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 4.0 t -111.63 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -60.11 168.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 306' ' ' VAL . 18.0 tt -69.79 -22.39 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.9 m -82.02 -19.29 40.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.501 ' CD ' ' N ' ' A' ' 299' ' ' GLU . 0.0 OUTLIER -103.61 51.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 299' ' ' GLU . 60.1 mt -130.77 -67.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.805 ' HG2' HG21 ' A' ' 306' ' ' VAL . 7.6 ptt180 -122.19 162.46 21.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -40.46 137.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -44.56 100.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.24 -132.31 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -119.7 69.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 301' ' ' ARG . 93.0 t -96.03 136.25 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.24 -57.13 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.708 ' OD1' ' HB3' ' A' ' 310' ' ' ALA . 10.5 t-20 -97.55 157.34 16.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.715 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t -108.01 -15.5 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 308' ' ' ASN . . . -50.41 -62.4 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.65 -16.82 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.705 HG12 HG13 ' A' ' 313' ' ' VAL . 73.6 t -75.24 -47.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 309' ' ' VAL . 29.1 m -138.05 153.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 74.9 m -105.69 164.02 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -83.14 119.61 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.07 22.58 41.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -98.36 132.74 43.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -73.95 124.9 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.06 164.51 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.495 ' HB3' HG11 ' A' ' 338' ' ' VAL . 33.7 mttt -107.03 135.72 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.67 160.52 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.153 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.0 ttmt -123.3 145.16 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.66 111.75 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.37 -41.04 18.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.6 t -167.39 150.87 6.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -140.01 123.44 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -144.46 116.96 8.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.67 -119.66 18.69 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 20.1 p -101.64 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 111.141 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -139.57 125.02 19.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.2 m -130.59 111.12 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -87.81 148.55 24.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 27.8 mt -142.27 146.97 35.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 4.3 t -118.81 132.84 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 66.2 mtp -94.64 -27.73 15.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 337' ' ' ASP . 3.7 mtmp? -78.04 -63.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.628 ' O ' HD12 ' A' ' 346' ' ' LEU . 11.7 t0 -34.45 -37.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 320' ' ' LYS . 94.8 t -95.24 106.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.41 ' CG ' ' CD ' ' A' ' 341' ' ' GLU . 5.7 t0 -53.05 135.11 37.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -85.33 33.0 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' CD ' ' CG ' ' A' ' 339' ' ' ASP . 6.2 pt-20 -118.56 -58.18 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.2 p -122.67 -26.81 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.174 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.69 6.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.435 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 165.29 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.572 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.8 t70 -92.8 97.18 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 337' ' ' ASP . 14.1 mt -88.64 39.81 0.94 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 322' ' ' LYS . 1.2 t30 -107.93 76.85 0.61 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -45.42 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.374 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.2 m120 -130.15 -35.99 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 349' ' ' ASN . 10.0 tpp180 -34.53 106.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -158.35 160.2 36.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.827 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -140.68 146.6 38.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -65.99 127.98 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.18 -53.84 8.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.7 m -108.36 90.07 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 m -66.41 102.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 54.23 -138.41 39.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.5 p -48.32 -52.23 22.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.0 m 48.18 41.24 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.81 84.05 0.31 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.23 -46.57 86.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.17 143.94 36.76 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.448 ' HB2' HG21 ' A' ' 323' ' ' VAL . 54.4 Cg_endo -69.72 163.72 37.17 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.397 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.4 m -111.58 127.75 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.449 HD13 HD13 ' A' ' 354' ' ' LEU . 76.9 mt -61.98 130.64 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.88 37.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.534 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.1 151.4 23.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.3 mp -101.13 126.27 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -116.9 166.11 12.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -93.03 138.62 31.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.07 175.72 25.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 3.5 tmmm? -142.23 145.7 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.593 HG11 HD11 ' A' ' 275' ' ' ILE . 19.3 t -74.5 112.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 65.0 p -92.37 -36.27 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -149.43 124.38 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -91.5 132.89 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 15.7 mtm -120.84 144.93 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.27 -31.55 3.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 276' ' ' MET . 3.6 p90 -88.64 -60.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 295' ' ' VAL . . . -135.26 -166.88 11.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.69 134.29 42.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 15.6 m-85 -79.09 114.47 18.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.86 125.58 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -103.58 124.92 49.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 291' ' ' TRP . 49.1 mt -69.01 142.72 54.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.78 130.82 56.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.28 -58.34 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 89.0 mt -46.76 138.81 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.333 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -53.86 -50.52 66.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.44 ' HD2' ' CZ2' ' A' ' 291' ' ' TRP . 19.7 ttmt -89.41 110.73 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.12 118.56 5.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 284' ' ' LEU . 45.4 m95 -110.18 161.72 15.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -149.95 117.49 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -115.7 164.37 12.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.437 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 18.5 tp -109.18 128.69 55.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 279' ' ' GLY . 30.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -54.12 163.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER -58.78 -29.29 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 47.6 t -71.28 -31.91 68.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.92 46.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 34.8 mt -134.21 -68.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -103.85 114.55 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 33.6 ptt85 -71.31 -38.56 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 7.0 tp10 -130.49 107.07 8.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 143.5 159.88 8.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 36.9 mtp85 -94.22 119.04 32.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.861 0.362 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.61 ' HB ' HD11 ' A' ' 297' ' ' ILE . 44.4 t -119.61 137.25 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.44 -33.49 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -127.58 177.93 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.656 HG12 HG22 ' A' ' 313' ' ' VAL . 61.2 t -117.8 -28.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.61 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -40.49 -62.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.61 -25.42 66.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 313' ' ' VAL . 86.9 t -67.81 -39.03 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 309' ' ' VAL . 20.9 m -143.41 143.93 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.8 t -101.36 171.54 7.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -85.57 127.75 34.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.32 55.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -102.23 126.03 49.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.471 ' CD ' ' H ' ' A' ' 318' ' ' ARG . 2.1 mpt_? -68.09 136.19 53.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.57 164.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -110.31 138.27 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.428 ' C ' HG21 ' A' ' 338' ' ' VAL . 27.3 m -138.23 156.75 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.443 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.8 ttmm -112.64 138.4 49.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 262' ' ' PRO . 87.8 t -76.53 100.28 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 264' ' ' ILE . 80.4 mt -70.28 -50.32 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -159.72 128.87 5.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.16 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 327' ' ' THR . 5.8 t -142.98 109.38 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.61 -136.01 44.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.6 p -75.79 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 111.148 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 327' ' ' THR . 50.3 tttt -93.48 123.68 36.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.4 m -135.5 125.28 25.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 m -88.62 152.03 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 91.9 mt -148.98 132.27 16.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 96.8 p -112.19 136.1 52.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.425 ' HG2' HG12 ' A' ' 321' ' ' VAL . 68.2 mtp -104.75 -43.47 5.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -67.22 -28.05 67.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 16.35 5.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 322' ' ' LYS . 62.2 t -134.14 130.64 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 346' ' ' LEU . 10.9 t0 -81.97 126.19 31.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.78 9.28 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -99.69 -50.7 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 43.9 p -125.4 -21.63 4.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 86.03 30.48 22.94 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -74.29 176.27 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.35 96.19 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 339' ' ' ASP . 26.4 mt -92.74 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -130.42 74.41 80.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.23 5.93 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -105.56 63.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -138.48 108.01 6.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -107.49 -61.47 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.13 105.04 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -132.99 152.25 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 264' ' ' ILE . 6.6 mp -85.46 -49.94 7.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -82.16 -55.07 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.6 p -126.66 119.09 26.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -44.06 167.02 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.476 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.4 t -125.94 84.55 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.1 t -134.19 138.52 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -177.34 -54.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.98 -47.84 5.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.05 151.38 47.49 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.686 0.755 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.554 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.77 150.57 68.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.689 2.259 . . . . 0.0 112.342 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.1 m -100.38 130.24 46.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.76 131.9 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.46 -10.53 71.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -93.75 147.76 22.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 62.8 mt -96.13 128.46 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.44 164.47 21.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.19 135.89 35.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.38 166.07 28.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 20.3 ttpt -131.27 145.25 51.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 25.5 t -72.4 119.33 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 40.1 p -97.16 -33.02 11.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -151.71 127.04 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.797 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -94.47 124.99 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 23.9 mmt -109.2 153.18 24.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -54.1 -27.18 31.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 0.8 OUTLIER -91.6 -59.58 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.21 -166.23 10.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.0 p -127.98 134.45 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 294' ' ' LEU . 39.4 m-85 -86.76 107.16 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -105.27 129.91 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -93.89 129.58 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.648 HD21 HD22 ' A' ' 333' ' ' LEU . 81.7 mt -75.27 145.05 42.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.51 172.85 6.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.54 -49.44 3.86 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.62 132.41 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 288' ' ' ARG . 3.1 mmm180 -45.65 -52.21 11.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.02 89.34 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -43.76 116.26 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.554 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 79.0 m95 -95.27 146.1 24.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -115.63 115.94 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -119.36 166.36 13.24 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.0 tp -117.23 136.17 53.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.1 103.57 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -49.5 167.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.548 HD11 ' CG1' ' A' ' 306' ' ' VAL . 2.0 tp -65.86 -37.65 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.5 t -74.9 -2.6 27.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -108.03 36.74 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.612 ' HB3' HG11 ' A' ' 312' ' ' VAL . 42.5 mt -128.15 -63.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 306' ' ' VAL . 1.0 OUTLIER -79.43 123.91 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -70.68 -42.12 71.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -144.34 127.48 16.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 117.21 -174.87 15.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -95.77 137.13 35.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 301' ' ' ARG . 41.2 t -90.22 144.71 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -100.28 -66.36 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 312' ' ' VAL . 22.6 t30 -155.96 135.94 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 300' ' ' LEU . 39.1 t -53.41 -36.62 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.15 -56.09 7.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.28 -22.92 61.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 308' ' ' ASN . 94.0 t -71.26 -39.07 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 312' ' ' VAL . 27.5 m -145.49 157.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 m -113.45 164.09 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.64 127.07 31.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.72 36.13 58.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.481 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -105.64 131.98 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.898 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 319' ' ' VAL . 24.9 ptt180 -74.1 135.88 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 318' ' ' ARG . 12.3 m -155.47 170.23 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.83 131.53 55.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.663 HG12 ' HG2' ' A' ' 335' ' ' MET . 33.0 m -135.84 162.76 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 28.8 ttpp -117.79 144.61 45.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.96 106.2 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 334' ' ' SER . 53.3 mt -73.95 -50.99 17.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.1 t -160.7 149.53 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -127.89 119.62 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 327' ' ' THR . 8.9 t -144.56 113.98 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 52.9 -141.77 28.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -83.38 43.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -147.81 114.09 5.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 1.8 m -116.78 142.98 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.4 p -113.15 140.58 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.648 HD22 HD21 ' A' ' 284' ' ' LEU . 15.6 mt -134.56 155.35 50.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 324' ' ' LEU . 48.3 p -129.08 146.98 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.663 ' HG2' HG12 ' A' ' 321' ' ' VAL . 70.5 mtp -118.91 -54.77 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -49.11 -33.03 10.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.38 -23.17 43.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.47 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 70.7 t -102.14 107.16 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -52.17 129.73 28.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -84.49 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.0 -57.47 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 9.8 t -123.89 -33.09 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 108.5 31.38 3.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.03 142.19 41.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.54 108.57 7.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.57 34.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -125.14 80.91 63.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.681 0.753 . . . . 0.0 110.876 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -29.48 23.68 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.324 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -170.06 120.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -101.98 150.81 22.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.77 -66.29 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 354' ' ' LEU . 3.3 tpm_? -167.88 137.68 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.9 t-20 -54.32 83.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 354' ' ' LEU . 6.9 tt -57.87 118.76 5.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 353' ' ' ASN . 90.7 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.162 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 54.7 p -47.92 149.59 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.4 t -137.13 112.0 8.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 80.85 -87.69 1.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t 44.96 41.93 5.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 33.0 m -135.21 159.32 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.05 44.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -102.77 -46.53 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.19 148.54 39.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.632 0.73 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.75 175.44 8.09 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.268 . . . . 0.0 112.403 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 43.4 m -116.52 138.04 51.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.16 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.5 mt -75.7 128.74 37.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.27 67.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 149.89 24.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.53 129.68 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -122.94 165.49 16.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.05 133.56 46.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -146.26 167.51 27.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -133.28 142.6 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.88 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 275' ' ' ILE . 22.0 t -66.81 112.37 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 58.5 p -94.16 -32.06 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.1 m -147.93 131.5 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.656 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.4 mp -101.35 131.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.6 mmt -119.8 153.73 35.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -58.08 -14.73 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -104.12 -54.23 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.88 -171.53 15.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.4 ' CB ' HG21 ' A' ' 313' ' ' VAL . 22.3 p -126.81 134.78 50.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.506 ' CE1' HD13 ' A' ' 294' ' ' LEU . 25.2 m-85 -81.82 112.55 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.13 118.7 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.57 125.21 36.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 291' ' ' TRP . 35.1 mt -69.99 152.84 43.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -117.15 158.48 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 90.33 -68.26 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.3 mt -41.49 136.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.889 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -57.23 -51.14 70.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.443 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 23.0 ttmt -81.21 85.35 6.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -43.69 102.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.557 ' HB2' HD12 ' A' ' 284' ' ' LEU . 77.3 m95 -90.6 159.49 16.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.8 119.6 18.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.43 169.09 12.75 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.506 HD13 ' CE1' ' A' ' 281' ' ' PHE . 23.3 tp -124.55 130.3 52.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.42 100.77 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.459 ' CE1' HG22 ' A' ' 297' ' ' ILE . 28.6 t-80 -55.3 159.93 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.697 HD11 ' CG1' ' A' ' 306' ' ' VAL . 2.5 tp -56.95 -31.0 35.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 17.3 m -70.7 -15.67 62.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.2 OUTLIER -109.48 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 299' ' ' GLU . 80.0 mt -131.78 -56.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.535 ' HB2' HG22 ' A' ' 306' ' ' VAL . 26.7 mtm180 -129.83 148.21 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -102.87 -68.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -81.93 110.85 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.868 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 120.34 128.93 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -68.25 92.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.697 ' CG1' HD11 ' A' ' 297' ' ' ILE . 21.2 t -43.84 150.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 312' ' ' VAL . 67.0 t30 -150.92 129.54 12.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 275' ' ' ILE . 75.7 t -34.22 -50.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.42 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -37.79 -57.21 1.02 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.84 -20.94 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 308' ' ' ASN . 19.7 t -75.63 -64.68 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 309' ' ' VAL . 26.7 m -114.46 153.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 2.3 t -111.21 157.26 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -68.6 125.75 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.66 30.97 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -102.17 126.92 49.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -71.61 138.17 48.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.2 m -154.83 167.17 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -114.32 128.3 56.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 4.6 m -130.7 163.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 3.3 tppp? -113.97 144.42 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 93.6 t -80.89 102.38 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 264' ' ' ILE . 77.8 mt -69.7 -58.99 3.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 40.2 t -157.08 160.03 38.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.4 t80 -142.46 126.88 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -147.23 111.45 5.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.55 -115.27 7.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.2 t -107.41 37.09 2.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -132.89 123.8 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -127.13 114.8 18.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.3 m -88.32 132.64 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 284' ' ' LEU . 88.5 mt -129.37 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 324' ' ' LEU . 43.4 t -117.77 142.66 47.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 80.2 mtp -101.71 -52.29 3.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -51.07 -47.47 61.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.79 -20.29 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.91 120.57 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 343' ' ' GLY . 6.6 t0 -68.87 123.16 20.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -78.55 9.55 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -106.14 -39.48 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 4.2 p -127.61 -5.1 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 339' ' ' ASP . . . 54.25 42.0 72.14 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.54 177.83 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.928 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.72 119.11 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.21 23.21 11.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -119.63 80.72 23.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.923 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 349' ' ' ASN . 53.9 Cg_endo -69.77 -21.85 32.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 348' ' ' PRO . 9.2 m120 -161.82 130.64 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -149.05 148.52 29.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -74.2 116.05 14.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -106.64 110.46 22.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -107.64 115.43 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 26.8 tp -146.89 131.4 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.4 m -98.66 143.42 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.5 p -40.52 121.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.72 94.64 2.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.7 t -74.02 133.54 42.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 m -91.96 -58.58 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.826 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 84.56 -53.84 4.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -76.58 -57.83 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.13 143.77 27.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.06 22.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 47.8 m -116.66 128.67 55.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.41 133.78 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 94.08 -31.62 6.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 152.68 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 267' ' ' ILE . 4.7 mp -98.29 146.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -138.79 167.96 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -94.58 142.06 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.32 173.13 32.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.542 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -140.36 146.66 38.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 113.28 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.4 p -91.66 -32.26 15.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.3 m -151.94 126.61 9.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.1 mp -93.27 110.36 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -98.53 154.14 18.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.76 -43.07 72.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 2.6 p90 -73.2 -46.7 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.13 -161.2 10.51 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 26.7 p -131.06 132.11 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 294' ' ' LEU . 12.1 m-85 -79.69 110.26 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.46 131.12 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -104.07 127.79 51.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.62 146.01 40.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -118.91 116.66 26.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 287' ' ' LEU . . . 133.92 -67.13 0.56 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 25.6 mt -36.46 131.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.41 ' C ' ' HD2' ' A' ' 288' ' ' ARG . 0.7 OUTLIER -39.38 -54.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.04 134.82 34.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -70.53 97.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 66.6 m95 -90.04 133.48 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.72 120.4 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -125.39 155.3 18.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 281' ' ' PHE . 11.8 tp -109.61 155.38 21.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 294' ' ' LEU . 39.6 t -123.58 99.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -45.61 168.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 278' ' ' PHE . 16.2 tt -67.23 -29.79 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 89.5 p -70.3 -26.35 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.564 ' O ' HD23 ' A' ' 300' ' ' LEU . 5.1 mp0 -87.06 44.07 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.648 ' HB3' HG11 ' A' ' 312' ' ' VAL . 66.2 mt -133.7 -64.75 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.69 ' HB2' HG22 ' A' ' 306' ' ' VAL . 2.1 tpm_? -74.99 161.42 29.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -35.64 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.78 -43.7 62.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 306' ' ' VAL . . . 145.82 -78.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.464 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -47.49 140.42 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 301' ' ' ARG . 60.2 t -137.92 138.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.12 -69.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.788 ' O ' HG23 ' A' ' 312' ' ' VAL . 27.6 p-10 -160.05 139.69 11.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 313' ' ' VAL . 47.3 t -58.23 -41.58 81.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -41.36 -55.21 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.64 -27.78 62.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 308' ' ' ASN . 83.9 t -64.67 -60.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.148 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -111.06 179.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 70.8 m -132.16 166.76 21.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 275' ' ' ILE . 63.9 tttp -83.04 127.82 33.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 65.43 35.23 91.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -105.9 135.95 46.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -73.87 121.7 21.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.82 155.95 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -101.05 133.06 46.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 163.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 338' ' ' VAL . 6.1 ttpm? -124.22 135.09 53.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.22 110.8 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 334' ' ' SER . 86.5 mt -81.89 -48.42 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.6 t -167.0 143.28 4.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.509 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 35.2 t80 -131.07 128.96 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 327' ' ' THR . 9.8 t -149.9 111.85 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 61.33 -109.24 2.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.1 t -109.05 33.67 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -128.16 116.91 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 9.2 m -125.09 104.15 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.4 t -86.46 150.05 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -144.06 142.87 30.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 324' ' ' LEU . 1.3 t -114.37 156.85 23.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 57.4 mtp -125.52 -48.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -55.19 -28.47 53.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.12 38.0 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 322' ' ' LYS . 70.1 t -149.08 105.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -58.07 122.05 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -80.96 42.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.19 -43.08 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -130.38 -42.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 106.27 34.12 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.28 179.46 4.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.45 98.4 9.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.22 39.3 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -132.34 84.33 52.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.636 0.732 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -44.41 2.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.37 144.01 50.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.6 ttp85 -140.08 118.18 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -82.97 111.15 18.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.05 100.49 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -124.79 158.67 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.15 122.39 46.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 62.6 m -86.44 -53.42 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.895 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.6 t -123.72 -59.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 85.85 -178.15 49.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.5 t -102.68 103.13 13.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 24.0 m -50.34 -47.64 55.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.49 45.99 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -102.49 -53.85 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -113.73 151.9 45.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.681 0.753 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.9 Cg_endo -69.74 166.74 26.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.326 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.0 m -111.58 141.05 45.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 324' ' ' LEU . 71.9 mt -76.27 135.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.04 -11.46 70.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.98 155.48 17.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 95.2 mt -103.12 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -135.32 163.88 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.73 146.36 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -153.5 -179.35 28.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -145.28 140.78 28.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.72 108.61 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 72.7 p -81.72 -36.46 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.38 139.35 19.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.7 mp -103.22 122.58 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 1.2 mpt? -112.76 154.14 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -54.69 -33.59 61.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.1 p90 -81.93 -53.73 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.31 -160.3 8.94 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.15 129.86 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE2' HD13 ' A' ' 294' ' ' LEU . 46.7 m-85 -79.24 127.66 32.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.22 122.74 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -91.85 134.04 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.5 mt -76.4 146.22 38.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -122.64 141.91 51.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 111.32 -44.94 1.4 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.95 173.98 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -87.47 -47.51 8.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.492 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 35.7 tttt -86.99 121.31 29.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -62.32 104.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.492 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 27.4 m95 -97.18 162.53 13.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -149.93 116.42 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.74 171.15 13.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.3 tp -127.23 125.61 41.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.907 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.24 107.15 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.529 ' CE1' HG22 ' A' ' 297' ' ' ILE . 36.1 t-80 -59.56 163.06 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.693 HD11 ' O ' ' A' ' 306' ' ' VAL . 7.9 tt -61.68 -26.32 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 1.3 t -90.93 22.82 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -132.52 32.64 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.745 HD12 HG11 ' A' ' 306' ' ' VAL . 15.9 mt -119.73 -49.6 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.465 ' HD3' HG22 ' A' ' 306' ' ' VAL . 61.6 mtp85 -132.39 174.72 9.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -121.16 -52.59 2.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -84.51 -75.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -52.58 140.63 29.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -71.76 157.43 37.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 300' ' ' LEU . 57.4 t -128.85 98.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.16 -46.99 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -176.08 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 313' ' ' VAL . 41.4 t -121.25 -32.12 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.126 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.46 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -35.36 -62.5 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -67.29 -29.69 69.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 313' ' ' VAL . 92.1 t -61.78 -41.52 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.625 HG22 HG12 ' A' ' 309' ' ' VAL . 35.9 m -147.27 146.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 17.9 m -103.78 170.48 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -78.95 128.23 33.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.51 35.84 59.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.509 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -105.99 125.28 50.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.945 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -65.81 134.26 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.0 m -152.49 167.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -114.25 134.69 54.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -135.88 163.72 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -113.9 147.25 38.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.15 99.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 264' ' ' ILE . 79.1 mt -70.59 -60.53 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -155.34 156.02 34.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -134.39 130.59 37.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 13.1 p -143.18 108.2 4.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.142 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 50.63 -106.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 82.5 p -102.31 41.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -138.97 131.55 28.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 21.5 m -139.38 106.81 5.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 61.0 m -80.97 142.69 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 69.8 mt -138.64 131.4 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 47.9 t -107.19 147.25 30.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 321' ' ' VAL . 47.3 mtp -115.97 -45.07 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 43.7 pttt -57.76 -35.68 71.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 346' ' ' LEU . 80.5 m-20 -74.1 -15.03 61.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.87 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.87 137.69 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.448 ' CG ' HD21 ' A' ' 346' ' ' LEU . 24.0 m-20 -81.2 143.64 32.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -90.3 -6.63 54.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -85.28 -52.64 5.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 5.0 t -128.44 -28.83 2.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 90.74 33.71 8.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.489 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.3 142.09 48.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.88 103.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 337' ' ' ASP . 52.5 mt -76.86 -37.63 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.26 81.59 3.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.605 0.717 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -17.62 37.38 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 0.0 112.371 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -114.05 122.79 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -107.83 -60.56 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 42.2 mmm-85 -98.56 146.58 25.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -98.0 113.84 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.52 -60.36 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 354' ' ' LEU . 3.6 pp -72.41 120.3 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.3 t -124.34 101.54 7.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 0.0 110.864 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.6 t -52.51 98.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 167.41 100.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -137.39 127.49 26.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 110.842 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 64.4 p -113.38 115.08 27.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.61 -38.91 1.68 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.65 -57.73 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -101.52 144.29 28.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 291' ' ' TRP . 53.5 Cg_endo -69.8 162.61 41.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 98.9 m -104.56 136.38 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.8 mt -71.89 131.38 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.33 -17.53 57.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.64 147.11 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 345' ' ' ASP . 4.9 mp -93.11 143.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -142.5 157.98 44.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.76 139.2 32.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.88 -179.49 22.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -143.83 137.49 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 313' ' ' VAL . 56.1 t -66.49 115.79 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 70.4 p -95.74 -31.07 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -152.63 125.11 8.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -93.32 127.3 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 16.5 mmt -113.26 153.9 27.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -54.96 -27.79 46.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.1 p90 -90.53 -58.43 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.16 -165.62 10.41 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' ' 309' ' ' VAL . 31.7 p -131.06 131.19 44.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.893 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.0 m-85 -80.67 111.45 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 93.8 t -105.36 125.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -94.31 126.47 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.04 151.48 46.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -125.09 107.42 10.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 145.6 -59.0 0.5 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 262' ' ' PRO . 50.5 mt -53.17 131.87 37.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.771 0.32 . . . . 0.0 110.947 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -47.22 -48.01 24.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -81.77 119.74 24.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -63.87 97.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.496 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 54.7 m95 -93.89 153.29 18.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -137.54 119.5 15.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -114.88 168.36 12.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.4 tp -122.95 142.91 50.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 18.8 t -119.6 102.31 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.43 163.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 tp -59.72 -27.15 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 31.4 t -73.79 -22.45 59.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 0.3 OUTLIER -98.02 46.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 299' ' ' GLU . 43.6 mt -133.71 -59.13 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.972 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.452 ' HB2' HG22 ' A' ' 306' ' ' VAL . 1.3 mpt_? -119.39 132.97 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -51.63 169.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -40.63 120.03 1.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 173.57 -130.81 1.92 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -129.9 105.53 8.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.334 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 301' ' ' ARG . 48.5 t -104.77 140.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -90.39 -68.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 312' ' ' VAL . 18.8 p-10 -158.02 169.93 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 313' ' ' VAL . 3.0 t -76.21 -29.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.733 ' HB3' HD21 ' A' ' 308' ' ' ASN . . . -47.98 -58.46 4.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.42 -25.13 63.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 308' ' ' ASN . 98.7 t -67.21 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.632 HG13 HG12 ' A' ' 312' ' ' VAL . 30.1 m -121.57 162.19 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 p -118.35 161.75 19.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -68.11 125.14 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.78 60.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.487 ' HG2' HG13 ' A' ' 319' ' ' VAL . 19.4 tt0 -102.31 128.6 48.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.82 0.343 . . . . 0.0 110.944 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -71.83 114.44 9.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 317' ' ' GLN . 5.4 m -127.49 159.87 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -106.36 126.92 52.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 16.3 m -132.83 161.76 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.6 ' N ' HG21 ' A' ' 338' ' ' VAL . 0.3 OUTLIER -126.02 136.67 53.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.7 119.78 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 334' ' ' SER . 90.1 mt -87.13 -46.55 9.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 p -162.64 146.64 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.74 129.26 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 327' ' ' THR . 9.7 t -147.94 111.04 4.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.41 -100.27 0.52 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 329' ' ' THR . 6.1 m -122.6 30.73 6.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 111.167 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -121.6 121.83 38.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.9 m -122.79 104.49 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 57.8 m -80.39 144.66 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 96.6 mt -138.28 139.49 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -119.88 146.99 45.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.429 ' CG ' HG12 ' A' ' 321' ' ' VAL . 84.2 mtp -113.35 -48.93 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -61.27 -19.91 62.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 346' ' ' LEU . 57.7 m-20 -93.04 -7.26 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.6 HG21 ' N ' ' A' ' 322' ' ' LYS . 93.3 t -118.06 133.2 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.149 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.19 163.85 27.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -118.44 -23.92 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -74.21 -31.7 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 42.3 p -133.3 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 83.96 38.62 10.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 344' ' ' GLU . 0.1 OUTLIER -88.34 -175.84 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 267' ' ' ILE . 4.1 t70 -93.11 104.87 17.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 337' ' ' ASP . 43.6 mt -79.24 -32.73 43.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 348' ' ' PRO . 64.3 t30 -127.87 87.99 54.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 347' ' ' ASN . 53.4 Cg_endo -69.78 1.28 4.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.307 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -157.37 113.07 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 160.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -74.9 -43.94 51.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -75.1 -50.83 15.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -41.18 134.76 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.91 -59.38 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.15 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 35.2 t -72.18 129.57 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 99.9 p -99.64 176.67 5.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -40.21 -73.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.6 m -113.97 169.93 8.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.369 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.6 m -150.43 121.92 7.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -176.5 66.89 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -113.75 -55.88 2.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -114.93 149.46 42.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.66 0.743 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.83 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.319 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 11.7 m -96.32 126.09 41.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.04 131.23 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.28 65.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -95.98 151.83 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.05 141.27 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -139.22 161.37 37.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -92.06 138.09 31.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -144.99 169.64 26.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.495 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -138.1 138.93 39.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.12 116.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.3 p -94.52 -31.63 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -152.33 139.67 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -104.57 117.1 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 19.5 mmt -105.37 153.94 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -55.74 -27.83 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.5 p90 -88.59 -54.28 4.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -147.7 -159.93 8.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.04 134.73 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 294' ' ' LEU . 47.5 m-85 -81.51 123.94 29.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' A' ' 270' ' ' GLY . 48.4 t -116.09 119.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.75 124.66 34.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.752 HD12 ' HB2' ' A' ' 291' ' ' TRP . 71.9 mt -68.97 147.44 51.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -129.58 98.71 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -49.35 0.43 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.417 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 32.5 mt -63.7 130.44 44.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.761 0.315 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 287' ' ' LEU . 7.8 ttt180 -37.59 -44.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -97.26 135.12 39.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.417 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -71.24 119.75 15.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.752 ' HB2' HD12 ' A' ' 284' ' ' LEU . 42.8 m95 -115.26 115.09 26.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.97 118.54 33.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 163.57 12.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.522 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 281' ' ' PHE . 22.4 tp -116.04 145.85 42.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.833 0.349 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 299' ' ' GLU . 6.4 t -121.08 98.3 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.1 t-80 -52.05 165.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 296' ' ' HIS . 19.9 tt -61.72 -35.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.4 t -71.44 -9.28 57.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.401 ' HB2' HG12 ' A' ' 295' ' ' VAL . 38.0 mt-10 -103.01 34.95 2.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.913 HD13 HG11 ' A' ' 312' ' ' VAL . 80.5 mt -123.84 -49.67 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 306' ' ' VAL . 61.7 mtt180 -139.16 112.52 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -51.76 -48.34 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.38 -48.31 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -39.32 111.3 0.19 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -55.3 104.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 301' ' ' ARG . 99.2 t -78.81 112.53 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -75.02 -63.62 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 312' ' ' VAL . 50.2 t30 -150.0 128.4 12.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 60.8 t -43.92 -43.54 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -42.17 -57.86 2.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.58 -24.74 63.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 300' ' ' LEU . 95.9 t -68.14 -62.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 312' ' ' VAL . 34.4 m -117.68 158.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.4 m -110.36 175.98 5.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -84.78 128.15 34.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.27 34.68 86.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.76 0.314 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 318' ' ' ARG . 26.4 mtm105 -73.33 122.66 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 8.7 m -142.33 168.5 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.449 ' CD ' ' HA3' ' A' ' 343' ' ' GLY . 63.5 mttm -111.53 136.8 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.748 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -133.1 161.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 0.0 OUTLIER -111.39 141.87 44.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.46 105.85 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.93 -58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -153.94 139.17 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -123.51 120.79 33.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.42 112.0 5.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.127 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.76 -134.47 51.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.448 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 329' ' ' THR . 20.5 m -84.43 34.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -132.58 132.22 42.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 7.7 m -138.26 111.62 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.3 m -81.61 150.92 27.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 321' ' ' VAL . 28.5 mt -148.36 141.64 25.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 53.4 p -118.29 150.58 39.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.748 ' HG2' HG12 ' A' ' 321' ' ' VAL . 23.4 mtp -127.71 22.09 6.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -115.76 -41.55 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -86.94 25.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 59.9 t -141.35 140.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 341' ' ' GLU . 14.3 t70 -84.86 164.79 18.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -114.14 -25.32 8.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 339' ' ' ASP . 5.3 tp10 -70.9 -39.95 72.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 13.0 p -131.79 -31.57 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.449 ' HA3' ' CD ' ' A' ' 320' ' ' LYS . . . 81.38 40.19 11.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.3 132.9 39.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -38.45 118.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 78.6 mt -98.05 -23.87 15.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -120.75 77.21 29.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -45.77 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.256 . . . . 0.0 112.389 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 350' ' ' ARG . 2.0 p-10 -39.34 -44.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 349' ' ' ASN . 27.2 ttt180 -34.98 -46.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -56.88 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -86.76 97.51 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -74.8 159.03 32.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 15.1 tp -171.34 131.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.151 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.4 t -48.16 103.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -109.91 41.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 124.75 -158.75 19.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.421 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.6 m -96.07 88.48 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -83.51 146.76 28.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 287' ' ' LEU . . . 157.98 -71.93 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.517 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.82 -43.45 69.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -107.38 150.07 39.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.609 0.718 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 178.0 5.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.361 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.1 m -131.42 126.29 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 324' ' ' LEU . 67.1 mt -60.81 133.56 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.123 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 91.12 -23.07 26.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.469 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.29 147.52 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 345' ' ' ASP . 71.6 mt -95.03 141.34 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -138.03 162.01 35.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.0 131.83 36.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.95 149.63 21.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.514 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -117.63 144.47 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 275' ' ' ILE . 25.1 t -70.98 110.76 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 41.2 p -88.92 -34.32 16.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 m -151.13 135.68 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.826 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.7 mp -101.19 136.66 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 3.7 mpp? -127.15 151.34 48.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -53.36 -28.17 27.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.4 -56.47 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.27 -168.5 12.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.466 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.1 p -127.19 129.64 48.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.447 ' N ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -75.81 110.09 9.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.3 t -106.69 128.18 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -104.38 126.7 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 291' ' ' TRP . 30.1 mt -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.72 132.82 54.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 118.83 -66.41 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 259' ' ' GLY . 38.1 mt -42.52 133.79 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -45.75 -51.04 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -84.03 148.34 26.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.13 110.48 21.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.438 ' HB2' HD12 ' A' ' 284' ' ' LEU . 71.8 m95 -107.52 129.01 55.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -119.7 116.14 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -109.4 170.83 14.69 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.495 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -120.67 128.63 53.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.7 t -108.51 100.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -49.85 165.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 278' ' ' PHE . 18.5 tt -70.72 -5.82 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 t -89.12 -15.23 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.35 33.81 3.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 312' ' ' VAL . 62.8 mt -128.39 -33.61 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.416 ' NH1' ' HA ' ' A' ' 305' ' ' ARG . 15.8 ptt85 -124.01 122.75 38.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -62.76 -56.49 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -143.72 139.32 29.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 132.37 -134.23 7.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.515 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . 0.416 ' HA ' ' NH1' ' A' ' 301' ' ' ARG . 20.0 ttm-85 -171.06 127.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 312' ' ' VAL . 86.7 t -121.2 148.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -58.94 -62.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.2 OUTLIER -156.85 163.52 39.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 313' ' ' VAL . 21.4 t -55.87 -33.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -42.7 -56.02 3.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.42 -15.97 61.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 313' ' ' VAL . 90.5 t -76.95 -61.4 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 309' ' ' VAL . 32.7 m -123.08 151.56 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 4.4 t -103.65 174.69 5.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -85.36 126.55 33.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 79.66 30.56 43.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.464 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -104.14 116.64 32.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 126.27 28.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.57 169.58 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -109.74 127.91 54.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 335' ' ' MET . 28.6 m -131.69 156.42 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 1.1 ttmp? -114.26 141.24 47.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.4 108.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 264' ' ' ILE . 49.2 mt -75.77 -57.44 3.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.8 t -153.02 140.17 19.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -116.23 132.27 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 328' ' ' GLY . 1.5 p -132.01 168.82 17.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 327' ' ' THR . . . -30.42 -58.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 65.2 p -134.84 47.02 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.901 0.382 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.424 ' CB ' ' OG1' ' A' ' 327' ' ' THR . 0.3 OUTLIER -148.35 127.28 12.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.7 m -130.87 106.56 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 333' ' ' LEU . 61.3 m -87.73 153.69 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 332' ' ' SER . 28.5 mt -148.73 141.99 25.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.3 t -121.0 147.05 46.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.525 ' HG2' HG12 ' A' ' 321' ' ' VAL . 72.6 mtp -114.4 -37.03 4.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -67.32 -22.97 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.15 16.33 15.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 90.9 t -141.91 136.26 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.67 162.57 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -115.31 -29.09 6.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -67.7 -39.43 84.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 18.8 p -127.32 -31.94 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.122 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 87.41 33.23 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.93 174.62 10.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 267' ' ' ILE . 1.5 t0 -89.97 105.62 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.5 36.45 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -126.58 81.08 68.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.892 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.0 6.95 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.714 2.276 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -141.07 105.33 4.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 351' ' ' ARG . 23.9 ttp180 -93.48 -61.91 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 350' ' ' ARG . 7.2 tpp85 -34.5 99.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.09 85.74 7.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.71 -60.64 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 354' ' ' LEU . 0.8 OUTLIER -44.89 117.86 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.9 p -97.28 97.34 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.0 p -164.65 141.77 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 67.77 121.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.1 m -136.65 140.26 42.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.7 t -54.37 156.88 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 164.88 -41.26 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -75.64 -58.63 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -91.67 144.07 28.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.657 0.742 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' A' ' 287' ' ' LEU . 54.1 Cg_endo -69.73 -168.27 0.26 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 91.1 m -133.09 139.49 47.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.9 mt -69.76 137.55 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.79 8.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.87 144.09 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.79 135.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.71 167.61 17.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -98.48 135.29 40.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 319' ' ' VAL . . . -146.22 171.57 27.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.492 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -137.57 147.96 45.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.864 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 34.7 t -75.54 119.83 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 76.6 p -97.27 -31.3 12.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -152.41 131.94 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.9 mp -99.06 128.95 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 4.2 mpp? -120.16 151.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -53.71 -29.18 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 2.4 p90 -87.33 -55.25 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.85 -168.15 13.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.569 ' HB3' HG11 ' A' ' 309' ' ' VAL . 28.8 p -129.98 132.45 46.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.422 ' CG ' ' HE1' ' A' ' 276' ' ' MET . 14.1 m-85 -78.14 119.51 21.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.03 120.95 66.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -91.58 127.85 37.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.97 154.76 40.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.3 148.74 51.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 105.26 -41.45 2.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 262' ' ' PRO . 67.5 mt -71.59 158.77 35.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.86 0.362 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -77.19 -52.41 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -76.83 113.18 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 116.42 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -115.49 145.47 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -141.77 118.83 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -111.66 169.32 13.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 23.5 tp -118.17 129.25 55.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 109.86 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 297' ' ' ILE . 29.9 t-80 -60.07 162.08 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.524 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.1 tp -60.09 -34.51 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 27.3 t -66.95 -29.76 69.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.446 ' O ' HD23 ' A' ' 300' ' ' LEU . 8.0 mm-40 -87.67 41.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 299' ' ' GLU . 76.5 mt -134.49 -65.21 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 306' ' ' VAL . 16.9 ttp180 -102.49 162.12 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -93.78 -42.9 8.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -44.31 169.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -42.82 -94.1 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -104.32 153.92 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 301' ' ' ARG . 22.5 t -104.13 150.24 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -70.81 -68.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.656 ' O ' HG23 ' A' ' 312' ' ' VAL . 46.4 t30 -158.86 146.97 18.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 280' ' ' CYS . 43.4 t -64.36 -41.46 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -34.21 -59.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -68.36 -30.05 68.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 313' ' ' VAL . 85.0 t -62.88 -58.29 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.666 HG13 HG12 ' A' ' 312' ' ' VAL . 34.5 m -128.35 151.12 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.0 p -103.65 176.02 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -80.7 130.95 35.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 67.28 33.07 81.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -100.82 129.5 46.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.764 0.316 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.59 135.22 52.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 270' ' ' GLY . 27.7 m -154.26 154.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -98.6 134.43 41.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.449 ' C ' HG21 ' A' ' 338' ' ' VAL . 29.4 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 338' ' ' VAL . 8.3 ttmm -119.56 143.8 47.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 58.7 t -78.31 102.55 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.139 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 334' ' ' SER . 27.1 mt -71.93 -54.99 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 79.5 p -155.51 152.6 29.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 7.0 t80 -135.75 126.27 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 327' ' ' THR . 5.6 t -147.85 113.37 5.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.43 -119.77 16.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 35.7 p -97.88 41.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.875 0.369 . . . . 0.0 111.145 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -135.56 130.85 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.5 m -137.39 107.77 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.41 ' O ' HD23 ' A' ' 333' ' ' LEU . 17.9 m -81.61 154.51 26.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 332' ' ' SER . 96.4 mt -145.22 140.47 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.653 ' HB3' HD21 ' A' ' 324' ' ' LEU . 96.9 p -118.03 142.42 47.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 55.1 mtp -114.49 -54.73 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -55.98 -29.54 60.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.94 -27.09 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 322' ' ' LYS . 73.2 t -92.91 115.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.13 112.22 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.59 -3.2 10.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -84.5 -43.63 14.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 22.1 p -133.26 -35.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 99.14 38.0 3.93 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -84.67 171.88 12.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 345' ' ' ASP . 2.6 t0 -89.81 99.12 12.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 347' ' ' ASN . 65.3 mt -88.44 -39.42 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -29.34 93.34 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.4 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.642 2.228 . . . . 0.0 112.331 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 351' ' ' ARG . 1.0 OUTLIER -163.71 123.39 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -79.47 -51.96 8.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.473 ' O ' ' ND2' ' A' ' 349' ' ' ASN . 14.7 tpp85 -49.0 143.46 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . 0.42 ' HD3' ' C ' ' A' ' 352' ' ' ARG . 0.9 OUTLIER -113.58 -33.52 5.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 354' ' ' LEU . 7.6 t30 -142.93 133.71 25.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 354' ' ' LEU . 0.0 OUTLIER -143.05 -179.15 6.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 m -98.96 167.57 10.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.5 t -63.67 99.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 153.63 90.31 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 4.1 t -58.32 168.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.4 p -97.55 -59.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.551 ' O ' HD22 ' A' ' 287' ' ' LEU . . . 115.24 -69.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.61 -49.23 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 261' ' ' GLU . 0.3 OUTLIER -77.1 141.41 67.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.505 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.8 Cg_endo -69.77 179.87 3.4 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 85.0 m -134.43 136.57 43.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.26 146.16 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 84.41 -34.33 3.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.428 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.38 139.4 42.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 69.8 mt -87.07 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -141.47 160.1 40.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.72 133.8 41.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.98 170.7 26.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.61 144.71 48.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.05 114.56 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 34.7 p -92.62 -31.92 14.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.7 m -152.82 129.72 10.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.0 mp -95.16 110.67 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.166 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 24.5 mmt -94.81 153.98 17.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -53.17 -36.63 61.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -82.53 -57.07 3.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -141.89 -166.91 11.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.62 ' HB3' HG11 ' A' ' 309' ' ' VAL . 30.0 p -127.22 128.53 46.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 294' ' ' LEU . 37.1 m-85 -78.51 114.94 17.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.6 t -108.85 122.31 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -91.67 124.73 36.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 291' ' ' TRP . 51.5 mt -67.33 147.82 52.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -120.73 107.65 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 150.41 -73.53 0.28 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 259' ' ' GLY . 66.6 mt -41.6 136.15 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.342 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -49.91 -41.53 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -90.8 110.9 22.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -58.25 112.98 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' HB2' HD12 ' A' ' 284' ' ' LEU . 82.9 m95 -101.21 151.97 21.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.3 116.0 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.35 162.26 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 281' ' ' PHE . 14.4 tp -116.86 149.51 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.73 101.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 297' ' ' ILE . 31.1 t-80 -56.55 157.34 5.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 308' ' ' ASN . 12.5 tt -51.54 -39.05 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.403 ' N ' HG23 ' A' ' 297' ' ' ILE . 17.6 t -57.91 -36.95 73.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.843 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.07 43.33 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 309' ' ' VAL . 57.7 mt -134.99 -40.76 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.437 ' C ' ' HD3' ' A' ' 336' ' ' LYS . 0.0 OUTLIER -126.17 136.21 52.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 303' ' ' GLU . 12.4 ptt-85 -83.27 -38.11 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 302' ' ' ARG . 8.2 tp10 -138.41 150.66 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.61 -161.99 19.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.53 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 305' ' ' ARG . 4.4 tmm_? -143.02 114.22 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.448 HG11 ' CG2' ' A' ' 312' ' ' VAL . 64.7 t -103.52 138.61 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.169 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -46.15 -70.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.544 ' HA ' HD12 ' A' ' 297' ' ' ILE . 10.1 t30 -159.9 172.2 18.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.822 HG12 HG22 ' A' ' 313' ' ' VAL . 13.0 t -53.23 -38.08 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -40.5 -56.66 2.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.95 32.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 313' ' ' VAL . 96.4 t -133.14 -47.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.822 HG22 HG12 ' A' ' 309' ' ' VAL . 35.8 m -131.13 153.49 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 9.4 p -109.95 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -86.3 119.42 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.95 28.61 30.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.423 HE21 ' CG1' ' A' ' 319' ' ' VAL . 8.7 tt0 -104.01 131.49 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.0 110.928 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -74.28 139.73 44.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.423 ' CG1' HE21 ' A' ' 317' ' ' GLN . 35.1 m -151.67 164.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -111.26 121.44 45.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 333' ' ' LEU . 33.1 m -128.65 158.14 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -115.68 144.32 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.29 111.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 334' ' ' SER . 78.4 mt -83.2 -44.24 15.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -161.7 141.37 10.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -128.49 126.74 41.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 29.8 p -142.16 110.44 6.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 53.09 -104.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 329' ' ' THR . 8.5 m -105.22 31.71 4.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.858 0.361 . . . . 0.0 111.168 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -123.68 128.57 49.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.431 ' OG1' ' CE3' ' A' ' 291' ' ' TRP . 15.0 m -134.22 106.01 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 333' ' ' LEU . 8.6 t -81.08 156.88 25.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 332' ' ' SER . 61.5 mt -147.86 135.84 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.625 ' HB2' HD11 ' A' ' 324' ' ' LEU . 8.2 t -116.58 136.85 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 49.7 mtp -96.92 -47.85 5.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.437 ' HD3' ' C ' ' A' ' 301' ' ' ARG . 5.8 mtmp? -52.02 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 347' ' ' ASN . 11.5 m-20 -37.89 -44.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.38 118.05 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.28 126.28 28.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.34 36.98 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -128.79 -38.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.2 p -134.46 -41.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 109.15 33.19 2.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.31 166.05 14.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.67 98.74 11.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.81 -40.64 28.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 337' ' ' ASP . 35.4 t-20 -134.65 87.69 30.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -31.01 21.5 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -141.38 134.31 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.417 ' HG2' ' N ' ' A' ' 351' ' ' ARG . 0.0 OUTLIER -114.84 -28.94 6.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 350' ' ' ARG . 1.9 tmm_? -108.47 129.1 55.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -42.51 155.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -93.38 92.32 7.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.15 -60.62 2.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.085 179.901 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 34.4 t -96.52 122.32 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 p -112.32 -34.41 5.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 76.83 -140.57 25.15 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.5 p -107.69 175.39 5.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 59.7 m -124.08 -60.25 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 142.03 -40.39 1.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -87.95 -57.31 2.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -81.64 143.38 50.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.662 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.8 Cg_endo -69.77 150.2 67.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.339 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 37.1 m -104.82 131.81 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 64.4 mt -61.18 133.7 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 98.75 -32.26 7.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.483 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.91 155.74 32.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 75.1 mt -105.3 130.54 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -123.04 164.1 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -93.73 141.58 28.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -147.46 173.56 27.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.0 OUTLIER -141.74 145.6 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 24.3 t -73.25 116.84 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.1 p -96.1 -39.88 9.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.8 m -146.08 126.37 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 309' ' ' VAL . 3.9 mp -93.1 121.23 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.577 ' CE ' ' CD2' ' A' ' 281' ' ' PHE . 3.7 mpp? -110.17 153.9 24.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -51.35 -39.91 58.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.8 p90 -76.59 -58.08 3.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.52 -166.61 11.93 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -126.0 137.82 53.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.577 ' CD2' ' CE ' ' A' ' 276' ' ' MET . 16.7 m-85 -81.54 121.87 26.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.58 122.31 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -99.16 128.6 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 291' ' ' TRP . 36.9 mt -67.13 146.95 53.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -125.72 105.89 9.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.454 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.8 mt -70.49 124.94 25.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -43.85 11.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.585 ' HG2' ' CZ2' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -78.57 97.34 5.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -49.44 117.02 1.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 284' ' ' LEU . 35.4 m95 -116.97 151.25 37.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -140.4 115.98 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.92 162.52 12.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.06 144.83 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.21 101.1 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.464 ' CE1' HG22 ' A' ' 297' ' ' ILE . 32.4 t-80 -56.21 153.47 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 300' ' ' LEU . 9.5 tt -50.11 -39.99 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 99.5 p -62.88 -28.2 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -89.99 40.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 48.7 mt -132.17 -34.04 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.447 ' NH1' ' HB2' ' A' ' 301' ' ' ARG . 0.0 OUTLIER -123.55 177.18 5.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -107.19 -43.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -163.51 138.69 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 152.34 -140.19 7.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -149.74 105.92 3.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 t -141.18 137.82 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.27 41.34 3.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -159.79 173.99 15.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 275' ' ' ILE . 92.0 t -134.69 -36.29 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -47.37 -53.57 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.84 22.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 96.0 t -116.72 -39.56 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 275' ' ' ILE . 9.1 m -127.69 166.96 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 24.3 m -120.01 142.04 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -68.42 130.71 43.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 71.09 31.75 66.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.04 137.7 42.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.91 131.16 38.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.93 165.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -109.43 132.09 54.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.09 157.42 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 8.1 ttmm -118.84 139.92 50.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.662 HG21 ' HB2' ' A' ' 262' ' ' PRO . 95.2 t -74.62 104.24 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 334' ' ' SER . 35.3 mt -78.32 -46.77 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.2 p -161.75 142.83 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -127.93 124.64 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 327' ' ' THR . 9.2 t -144.73 119.09 9.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.31 4.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 36.9 p -94.82 38.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 327' ' ' THR . 32.5 tttp -135.39 130.86 35.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 6.6 m -138.55 108.01 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -78.95 149.93 32.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.29 132.9 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.763 ' HB3' HD11 ' A' ' 324' ' ' LEU . 36.7 p -115.63 130.37 56.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 86.2 mtp -99.85 -54.52 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 346' ' ' LEU . 41.3 pttt -50.02 -36.26 27.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 5.2 t0 -62.39 -39.98 95.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 60.1 t -100.1 105.48 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -46.08 129.18 9.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -81.41 42.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -131.06 -51.73 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 11.9 t -123.08 -38.0 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 105.73 38.33 2.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.87 139.68 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.91 102.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 336' ' ' LYS . 85.3 mt -73.94 -36.05 64.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.14 81.31 1.25 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.639 0.733 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -43.12 2.81 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.335 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -92.05 103.26 15.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 ttt-85 -123.49 94.47 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 12.2 mtm105 -119.32 85.1 2.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -60.0 -42.66 94.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -162.08 154.24 19.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 355' ' ' VAL . 19.3 tp -108.73 107.47 17.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 355' ' ' VAL . 14.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.104 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 38.7 p -61.66 126.14 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.6 t -102.92 129.08 49.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 146.99 -177.22 25.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 67.5 m -95.3 116.67 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.7 t -130.03 91.7 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.817 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.45 59.42 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.44 ' C ' ' CD ' ' A' ' 260' ' ' GLU . 0.3 OUTLIER -109.62 -54.39 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -93.26 132.63 30.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.662 0.744 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.483 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.0 Cg_endo -69.78 139.73 40.87 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.674 2.249 . . . . 0.0 112.36 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 65.8 m -84.15 139.78 32.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.5 mt -75.17 139.53 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.75 -14.57 58.12 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.97 153.53 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 345' ' ' ASP . 79.5 mt -94.51 136.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -131.25 160.65 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -92.95 139.72 30.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.01 173.95 25.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 272' ' ' VAL . 1.8 ttmp? -141.9 143.18 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 271' ' ' LYS . 34.5 t -75.36 108.04 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 51.3 p -91.03 -36.13 14.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -146.3 123.99 11.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 310' ' ' ALA . 3.8 mp -90.61 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 16.2 mtm -128.83 149.51 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -51.33 -36.28 42.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.58 ' CZ ' ' SD ' ' A' ' 276' ' ' MET . 6.5 p90 -81.98 -54.8 5.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.75 -163.39 10.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.0 p -133.33 137.48 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 12.8 m-85 -80.08 113.0 17.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 76.7 t -108.22 116.3 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.8 126.89 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 291' ' ' TRP . 85.9 mt -72.03 147.24 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -115.22 154.25 29.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.81 -62.57 0.94 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 37.3 mt -51.06 139.52 17.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -63.35 -44.83 93.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -81.89 96.42 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -45.45 117.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.598 ' CH2' ' CE1' ' A' ' 326' ' ' PHE . 44.0 m95 -110.96 144.62 39.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -132.27 119.43 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -121.42 157.8 16.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.417 ' CD1' ' CE ' ' A' ' 276' ' ' MET . 10.1 tp -107.4 138.11 44.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.95 110.99 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -58.1 140.52 52.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 309' ' ' VAL . 13.0 tt -50.22 -26.77 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.7 m -70.58 -31.87 69.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.823 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' A' ' 336' ' ' LYS . 0.4 OUTLIER -74.61 -21.52 59.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.1 -63.15 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -98.97 125.68 44.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -82.87 -34.54 26.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -39.66 -52.18 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 306' ' ' VAL . . . 148.89 -126.84 2.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.467 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -42.72 128.41 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.65 HG12 HD11 ' A' ' 297' ' ' ILE . 82.0 t -121.21 138.28 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -62.39 -72.28 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.115 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.733 ' O ' HG23 ' A' ' 312' ' ' VAL . 19.3 t30 -157.89 138.6 13.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.682 HG23 HD12 ' A' ' 297' ' ' ILE . 95.6 t -52.02 -48.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.116 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 275' ' ' ILE . . . -38.55 -57.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.48 -24.95 63.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 308' ' ' ASN . 84.4 t -70.29 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 309' ' ' VAL . 31.2 m -100.23 170.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.2 m -125.02 149.51 47.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 275' ' ' ILE . 2.4 tppp? -69.44 136.51 51.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.65 30.84 77.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -104.23 129.34 52.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.48 126.69 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.87 155.29 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.664 ' C ' HG11 ' A' ' 338' ' ' VAL . 60.5 mttm -106.32 134.32 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 333' ' ' LEU . 17.8 m -137.2 162.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 323' ' ' VAL . 5.3 tppt? -109.69 146.8 34.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 322' ' ' LYS . 36.0 t -84.26 101.78 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 334' ' ' SER . 74.9 mt -69.3 -53.2 20.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 43.7 t -165.05 149.76 9.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.598 ' CE1' ' CH2' ' A' ' 291' ' ' TRP . 34.6 t80 -127.54 123.1 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.3 t -143.63 108.02 4.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.85 33.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 9.9 t -97.02 39.19 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.67 117.9 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 18.2 m -118.19 114.86 23.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 74.2 m -87.4 140.59 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 321' ' ' VAL . 53.6 mt -135.25 152.68 51.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 324' ' ' LEU . 34.0 p -137.28 132.54 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.487 ' HG2' HG12 ' A' ' 321' ' ' VAL . 56.3 mtp -94.34 -34.74 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 299' ' ' GLU . 30.7 mtmt -46.75 -54.5 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 338' ' ' VAL . 1.6 p-10 -80.42 42.61 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.664 HG11 ' C ' ' A' ' 320' ' ' LYS . 89.4 t -161.1 112.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.583 ' OD1' HD11 ' A' ' 346' ' ' LEU . 29.3 m-20 -72.27 130.12 40.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.18 25.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.3 -43.71 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.5 p -129.76 -35.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 97.1 36.45 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.515 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 345' ' ' ASP . 24.8 tt0 -76.31 153.56 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.882 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.555 ' HA ' HD11 ' A' ' 267' ' ' ILE . 7.8 t0 -79.66 86.31 5.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.583 HD11 ' OD1' ' A' ' 339' ' ' ASP . 8.7 mt -70.19 -34.44 72.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 346' ' ' LEU . 21.0 t-20 -29.16 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.583 0.706 . . . . 0.0 110.845 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.492 ' N ' ' O ' ' A' ' 346' ' ' LEU . 53.6 Cg_endo -69.79 -37.62 8.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.239 . . . . 0.0 112.366 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -146.45 134.42 21.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 351' ' ' ARG . 5.9 tpt180 -114.39 -51.07 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -37.35 145.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.33 164.45 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.67 52.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.77 95.49 5.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 67.3 m 39.44 45.15 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.3 t -102.47 86.16 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 151.01 122.47 1.05 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.522 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 31.3 t -110.65 -53.25 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.8 t -99.62 123.33 43.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -129.55 166.5 21.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' A' ' 261' ' ' GLU . 7.2 pt-20 -108.85 -56.48 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.863 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 260' ' ' GLU . 4.3 mm-40 -126.63 152.5 74.75 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 0.0 110.857 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.584 ' HD3' HD13 ' A' ' 287' ' ' LEU . 53.9 Cg_endo -69.71 151.03 69.29 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.703 2.269 . . . . 0.0 112.356 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 26.7 m -108.47 151.03 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 83.6 mt -73.9 144.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 322' ' ' LYS . . . 82.5 -28.63 3.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 151.19 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.318 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.16 132.15 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -126.17 165.29 19.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.2 135.1 40.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.99 175.77 25.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -138.72 143.12 38.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 275' ' ' ILE . 26.8 t -70.59 110.98 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.096 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -89.02 -33.61 17.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.2 t -152.6 140.47 20.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.8 mp -106.15 119.35 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.576 ' CB ' ' CE1' ' A' ' 278' ' ' PHE . 0.7 OUTLIER -110.33 154.0 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -54.99 -27.51 44.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 276' ' ' MET . 1.1 p90 -87.56 -54.44 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -151.28 -174.01 21.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 28.5 p -120.84 128.5 52.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 294' ' ' LEU . 43.2 m-85 -76.36 123.71 26.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.24 124.59 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -96.47 127.33 42.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 291' ' ' TRP . 41.8 mt -66.98 149.5 50.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -129.84 97.54 4.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.92 -60.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.584 HD13 ' HD3' ' A' ' 262' ' ' PRO . 27.8 mt -55.03 140.24 38.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.63 -56.02 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -74.3 138.12 43.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 14.5 ttp-105 -77.09 118.58 19.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.842 ' HB2' HD12 ' A' ' 284' ' ' LEU . 81.9 m95 -106.1 165.97 10.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -149.66 116.12 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.32 16.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 281' ' ' PHE . 16.8 tp -114.51 130.06 56.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 299' ' ' GLU . 21.5 t -98.94 99.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 297' ' ' ILE . 17.9 t-80 -50.93 164.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.09 -31.28 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.3 t -75.35 -26.03 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.81 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 295' ' ' VAL . 0.2 OUTLIER -90.64 43.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.642 HD13 HG11 ' A' ' 312' ' ' VAL . 39.2 mt -117.13 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.498 ' CG ' HG21 ' A' ' 306' ' ' VAL . 9.4 ptp180 -160.41 113.06 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -57.05 -42.37 80.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 303' ' ' GLU . 6.3 pt-20 -66.84 109.85 3.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 93.44 141.93 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -84.61 83.51 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.498 HG21 ' CG ' ' A' ' 301' ' ' ARG . 37.0 t -62.01 154.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 306' ' ' VAL . . . -133.98 -52.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.688 ' OD1' ' HB3' ' A' ' 310' ' ' ALA . 8.9 t-20 -103.61 134.38 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.669 HG12 HG22 ' A' ' 313' ' ' VAL . 26.2 t -83.31 -25.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.688 ' HB3' ' OD1' ' A' ' 308' ' ' ASN . . . -48.78 -54.49 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.44 20.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 308' ' ' ASN . 88.3 t -115.54 -45.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 309' ' ' VAL . 33.8 m -126.31 169.49 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 75.7 m -120.12 151.88 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -72.19 130.46 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.37 83.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -103.09 133.6 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 0.0 110.92 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -72.73 122.61 21.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.59 167.35 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -110.63 128.74 55.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 333' ' ' LEU . 34.2 m -128.21 164.92 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 265' ' ' GLY . 11.7 ttmm -122.09 138.29 54.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.03 108.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.151 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 334' ' ' SER . 69.0 mt -81.2 -43.51 19.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.7 t -156.47 165.64 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -153.37 120.98 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 1.6 p -147.34 112.09 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 59.41 -104.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 10.1 t -112.41 33.71 4.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -125.22 124.68 42.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 4.9 m -130.61 106.05 8.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 333' ' ' LEU . 24.9 m -78.45 149.49 33.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 321' ' ' VAL . 90.8 mt -141.24 134.44 29.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.685 ' HB2' HD11 ' A' ' 324' ' ' LEU . 17.1 t -116.83 130.62 56.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 63.3 mtp -98.71 -28.68 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -74.88 -24.3 58.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -91.81 12.85 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.502 HG21 ' C ' ' A' ' 321' ' ' VAL . 97.9 t -129.97 146.29 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.439 ' CG ' ' HG2' ' A' ' 341' ' ' GLU . 9.7 t0 -99.02 107.83 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -62.63 -16.33 56.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.526 ' OE1' ' CA ' ' A' ' 341' ' ' GLU . 0.1 OUTLIER -71.32 -64.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.403 HG21 ' OE1' ' A' ' 344' ' ' GLU . 0.9 OUTLIER -111.35 -35.59 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 94.11 32.68 7.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.403 ' OE1' HG21 ' A' ' 342' ' ' THR . 10.6 mt-10 -75.37 177.47 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.85 95.6 10.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.425 ' C ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 mt -83.39 20.07 1.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 12.7 t-20 -114.26 64.28 1.34 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.634 0.73 . . . . 0.0 110.912 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 346' ' ' LEU . 53.5 Cg_endo -69.8 -50.74 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -141.83 115.53 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 351' ' ' ARG . 49.5 ttp85 -98.61 49.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 350' ' ' ARG . 5.2 mpt_? -133.19 42.37 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -125.14 -50.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.61 144.17 38.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 25.5 mt -143.67 110.97 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.6 t -95.26 120.66 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.894 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 258' ' ' SER . 2.4 p -60.06 -35.63 75.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 38.87 66.12 0.7 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.4 t 71.14 47.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.409 ' CB ' ' HB2' ' A' ' 255' ' ' SER . 41.3 t -75.0 109.34 8.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -165.38 55.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -103.0 -58.82 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.0 146.21 31.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.646 0.736 . . . . 0.0 110.853 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 323' ' ' VAL . 53.7 Cg_endo -69.74 148.5 65.37 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.297 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.1 m -94.56 126.5 39.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 91.2 mt -65.41 131.17 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.121 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.29 -10.72 69.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -99.82 148.48 24.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.453 ' C ' ' CD1' ' A' ' 268' ' ' TYR . 3.2 mp -89.51 149.32 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 267' ' ' ILE . 23.6 m-85 -145.0 163.23 34.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -92.44 145.63 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -144.93 171.87 25.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.482 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA2' ' A' ' 316' ' ' GLY . 0.1 OUTLIER -146.03 120.33 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.0 121.81 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 77.5 p -104.09 -32.13 9.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.0 m -150.96 124.29 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 275' ' ' ILE . 4.2 mp -92.09 146.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.558 ' SD ' ' CE2' ' A' ' 281' ' ' PHE . 3.7 mpp? -133.93 151.8 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.01 -22.25 14.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.555 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 0.5 OUTLIER -95.53 -54.97 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.46 -161.27 9.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.95 136.01 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.558 ' CE2' ' SD ' ' A' ' 276' ' ' MET . 29.6 m-85 -82.27 110.42 17.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 71.6 t -104.62 121.87 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -94.16 120.99 35.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.29 159.42 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -131.22 161.42 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.15 -57.31 2.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 22.0 mt -52.37 175.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -91.27 -57.79 2.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -77.93 109.14 11.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.49 108.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.54 ' CD1' ' HD3' ' A' ' 262' ' ' PRO . 26.3 m95 -104.46 121.37 43.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -106.88 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -112.51 164.32 12.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.9 tp -119.41 135.95 54.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.23 106.25 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -58.81 164.14 2.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.439 HD11 ' CG1' ' A' ' 306' ' ' VAL . 12.7 tt -64.34 -18.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.9 t -75.77 -24.15 55.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.01 47.45 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.427 ' CD1' ' HA ' ' A' ' 297' ' ' ILE . 49.9 mt -133.34 -57.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -120.96 136.46 54.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -99.11 -64.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.438 ' C ' ' CD ' ' A' ' 303' ' ' GLU . 0.3 OUTLIER -96.82 104.66 16.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 137.12 -164.2 25.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -117.09 155.18 29.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 297' ' ' ILE . 72.7 t -121.92 127.85 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -90.01 -58.49 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.8 OUTLIER -159.7 137.35 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.896 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.79 HG12 HG22 ' A' ' 313' ' ' VAL . 3.1 t -52.1 -39.52 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 308' ' ' ASN . . . -37.35 -56.55 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.51 -23.21 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 309' ' ' VAL . 90.2 t -69.45 -61.93 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.79 HG22 HG12 ' A' ' 309' ' ' VAL . 28.7 m -115.1 160.76 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 14.4 m -107.53 177.54 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 275' ' ' ILE . 28.9 tttp -93.26 119.46 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . 0.491 ' HA2' ' CE ' ' A' ' 271' ' ' LYS . . . 74.5 30.71 59.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.505 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -100.22 139.51 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -69.35 115.89 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.44 143.72 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.429 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 22.9 mtpt -97.37 128.29 44.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 333' ' ' LEU . 31.0 m -133.85 167.74 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 26.0 ttpt -123.14 146.14 48.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 262' ' ' PRO . 41.8 t -74.68 111.13 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.8 -47.08 12.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.6 t -169.69 153.37 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 326' ' ' PHE . 6.8 t80 -139.31 123.54 18.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 110.74 5.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 64.56 -110.58 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 69.9 p -112.09 42.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.378 . . . . 0.0 111.16 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -139.63 125.98 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.3 m -130.18 113.26 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.7 m -90.62 136.49 33.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 321' ' ' VAL . 46.8 mt -131.47 147.06 52.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 16.6 p -120.85 143.53 48.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 75.0 mtp -107.03 -36.02 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 338' ' ' VAL . 4.2 mtmp? -60.19 -70.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -38.76 -26.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.866 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 336' ' ' LYS . 49.9 t -99.58 130.97 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -79.97 119.81 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -66.62 -4.22 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -76.33 -56.15 4.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 343' ' ' GLY . 6.2 t -130.03 -45.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.468 ' N ' HG23 ' A' ' 342' ' ' THR . . . 122.98 28.7 1.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.449 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.6 150.21 43.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.85 99.41 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.14 -38.55 31.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.82 84.96 9.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.63 0.729 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -34.87 13.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -131.42 101.33 5.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -84.76 179.0 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -133.76 127.21 32.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 48.2 ttm-85 -123.13 108.32 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -142.41 129.52 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.65 -56.89 3.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 44.4 t -73.8 118.45 16.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.865 0.364 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 m -69.72 166.86 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 130.0 -54.57 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 38.7 m 46.77 42.42 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 47.3 t -86.91 82.06 7.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.89 98.06 0.34 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.38 -52.57 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -89.4 149.8 43.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.672 0.749 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.7 Cg_endo -69.78 165.81 29.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.697 2.265 . . . . 0.0 112.327 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 54.4 m -116.78 135.62 53.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 324' ' ' LEU . 84.6 mt -73.95 137.89 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.72 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.68 163.61 13.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 345' ' ' ASP . 47.6 mt -107.4 137.93 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.464 ' HD1' HG23 ' A' ' 323' ' ' VAL . 75.7 m-85 -130.66 162.08 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -93.17 135.67 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.95 28.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.458 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER -132.68 141.5 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.14 107.42 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 80.3 p -85.73 -31.69 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.9 m -152.77 132.44 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 275' ' ' ILE . 3.9 mp -98.62 126.31 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 21.9 mmt -111.77 153.48 26.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -55.46 -27.21 46.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -90.44 -55.63 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -145.93 -167.71 12.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.406 ' HB3' HG11 ' A' ' 309' ' ' VAL . 22.4 p -125.72 133.36 52.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.651 ' CZ ' HD13 ' A' ' 294' ' ' LEU . 39.1 m-85 -84.85 108.04 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 271' ' ' LYS . 88.1 t -104.02 122.78 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -91.65 130.12 37.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.0 mt -72.96 146.53 45.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -116.99 176.77 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 80.53 -58.73 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 33.3 mt -51.28 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 28.3 tpt85 -94.81 -58.94 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 291' ' ' TRP . 27.0 tttt -75.71 108.43 8.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.48 110.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 289' ' ' LYS . 31.3 m95 -102.65 137.58 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -123.01 117.1 24.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -117.47 155.86 15.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.651 HD13 ' CZ ' ' A' ' 281' ' ' PHE . 26.7 tp -107.37 142.33 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.51 98.94 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.423 ' CE1' HG22 ' A' ' 297' ' ' ILE . 18.5 t-80 -51.28 164.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.423 HG22 ' CE1' ' A' ' 296' ' ' HIS . 2.4 tp -62.08 -30.09 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.2 t -73.27 -11.47 60.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.21 39.59 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.649 HD13 HG11 ' A' ' 312' ' ' VAL . 72.4 mt -127.25 -53.69 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -122.29 143.27 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -43.56 165.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -41.58 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -171.95 -135.72 2.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -135.38 123.72 23.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.32 143.99 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -77.18 -69.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.767 HD22 ' HB3' ' A' ' 310' ' ' ALA . 5.1 p-10 -155.51 151.81 28.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 300' ' ' LEU . 59.4 t -62.09 -42.84 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.767 ' HB3' HD22 ' A' ' 308' ' ' ASN . . . -35.53 -59.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.64 -27.31 65.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 308' ' ' ASN . 91.1 t -66.69 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 312' ' ' VAL . 27.7 m -122.47 161.75 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.8 m -114.89 163.77 15.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -75.73 125.1 28.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 74.48 30.81 59.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -103.3 136.82 42.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.342 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -77.43 133.6 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 17.0 m -150.57 166.78 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -109.56 129.87 55.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.74 157.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.64 142.04 45.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.464 HG23 ' HD1' ' A' ' 268' ' ' TYR . 14.8 t -83.46 104.14 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 334' ' ' SER . 27.9 mt -77.05 -54.06 7.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.4 t -158.74 144.42 16.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -137.82 121.71 17.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.11 110.47 5.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.19 -125.71 24.76 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 74.0 p -95.46 45.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -146.05 123.38 11.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 5.4 m -132.96 110.38 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.5 t -83.12 156.37 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 80.5 mt -150.36 134.18 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' ' 324' ' ' LEU . 15.0 t -117.8 133.87 55.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.97 -39.66 6.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -58.62 -24.31 60.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.626 ' C ' HD12 ' A' ' 346' ' ' LEU . 1.4 m-20 -100.24 20.68 14.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 72.5 t -132.94 117.81 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.802 ' CG ' HD21 ' A' ' 346' ' ' LEU . 31.1 m-20 -64.19 110.12 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -71.13 -9.5 58.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -79.74 -45.04 19.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 31.1 p -131.57 -35.71 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 98.86 34.01 5.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 345' ' ' ASP . 15.7 tm-20 -73.95 165.73 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.908 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 344' ' ' GLU . 0.6 OUTLIER -83.71 93.39 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.802 HD21 ' CG ' ' A' ' 339' ' ' ASP . 38.0 mt -68.91 -32.53 72.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -114.54 81.8 7.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.65 0.738 . . . . 0.0 110.817 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -44.08 2.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -130.5 113.3 14.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -101.52 43.63 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.402 ' HD3' ' N ' ' A' ' 352' ' ' ARG . 2.4 tmt_? -114.79 133.41 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . 0.402 ' N ' ' HD3' ' A' ' 351' ' ' ARG . 31.0 ptt85 -138.08 151.25 47.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -63.39 133.54 54.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.24 118.38 4.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.3 t -83.34 44.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 79.8 p -108.72 41.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -119.22 147.95 18.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 76.7 p -119.45 41.9 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.842 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.3 p -94.73 129.34 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 170.32 125.78 0.83 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.68 -55.54 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -99.9 154.46 37.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.849 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 326' ' ' PHE . 53.6 Cg_endo -69.81 140.87 43.54 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 93.1 m -99.73 132.82 44.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.05 134.1 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 93.06 -15.26 63.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.32 140.82 29.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 74.7 mt -96.85 128.29 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.72 165.82 18.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -93.05 143.46 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 282' ' ' VAL . . . -145.07 170.33 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 282' ' ' VAL . 16.1 ttmt -144.66 138.99 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.65 113.49 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 55.5 p -98.94 -25.7 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.2 m -152.08 127.7 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.542 HG23 ' CG1' ' A' ' 309' ' ' VAL . 3.6 mp -98.21 120.76 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 22.8 mmt -106.67 153.05 22.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -54.14 -28.94 43.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 1.0 OUTLIER -89.14 -57.49 2.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.6 -168.92 12.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . . . . . . . . . 29.1 p -126.58 129.41 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.925 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 294' ' ' LEU . 41.1 m-85 -78.09 118.66 20.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.861 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 271' ' ' LYS . 65.2 t -110.39 119.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -90.65 125.23 35.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.76 145.79 48.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.74 96.76 5.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 158.06 -65.05 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 290' ' ' ARG . 56.5 mt -42.21 132.75 3.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -43.63 -39.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -100.35 112.05 24.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 287' ' ' LEU . 0.0 OUTLIER -55.07 96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.845 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.415 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 70.1 m95 -93.44 147.46 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.19 120.89 26.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -118.36 163.59 13.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 281' ' ' PHE . 14.2 tp -111.91 149.21 32.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.23 104.01 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -53.95 161.1 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 306' ' ' VAL . 17.7 tt -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 9.6 t -90.58 -23.26 20.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.95 39.98 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 65.2 mt -131.24 -46.25 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.443 ' HG3' HG22 ' A' ' 306' ' ' VAL . 31.0 mmm180 -118.65 138.91 52.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -84.9 -72.92 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.81 148.63 27.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 99.67 148.45 22.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.58 132.52 43.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 297' ' ' ILE . 60.8 t -98.77 140.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -86.9 -72.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.786 ' O ' HG23 ' A' ' 312' ' ' VAL . 3.3 t30 -155.86 149.86 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 313' ' ' VAL . 48.4 t -46.63 -43.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -43.42 -56.2 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.44 29.34 0.6 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 308' ' ' ASN . 46.8 t -130.09 -46.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.574 HG22 HG12 ' A' ' 309' ' ' VAL . 31.7 m -127.19 156.06 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 3.7 t -112.32 158.62 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -74.31 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 72.89 33.12 60.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -98.28 128.17 44.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.915 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -75.64 123.03 24.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.21 166.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.47 ' CE ' ' HA3' ' A' ' 343' ' ' GLY . 5.9 mtpm? -112.01 136.89 50.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.566 HG12 ' HG2' ' A' ' 335' ' ' MET . 34.2 m -139.07 165.49 23.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 27.2 ttpp -121.27 153.6 37.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.69 108.54 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.124 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 334' ' ' SER . 81.7 mt -81.38 -45.33 16.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.95 158.47 28.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 262' ' ' PRO . 53.3 t80 -145.64 119.02 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 329' ' ' THR . 29.5 p -139.55 111.1 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.6 -94.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' THR . 53.5 p -108.79 38.87 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.173 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -131.91 127.46 36.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 12.5 m -140.57 105.08 4.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 324' ' ' LEU . 26.8 m -86.29 153.24 22.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.25 130.54 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 324' ' ' LEU . 1.4 t -111.12 129.44 55.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.826 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.566 ' HG2' HG12 ' A' ' 321' ' ' VAL . 66.6 mtp -93.25 -33.55 13.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.465 ' O ' HD12 ' A' ' 346' ' ' LEU . 29.5 mtmt -68.39 -54.5 16.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.16 -19.75 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 63.6 t -117.89 105.67 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.628 ' OD1' HD11 ' A' ' 346' ' ' LEU . 32.5 m-20 -48.13 162.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -116.79 -9.4 11.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -94.1 -28.29 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.3 p -128.48 -35.24 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.47 ' HA3' ' CE ' ' A' ' 320' ' ' LYS . . . 79.13 31.41 42.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -83.94 -179.93 7.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 348' ' ' PRO . 1.4 t70 -95.58 92.8 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.628 HD11 ' OD1' ' A' ' 339' ' ' ASP . 29.6 mt -65.72 -30.76 71.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -127.79 84.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.928 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.49 ' N ' ' OD1' ' A' ' 345' ' ' ASP . 53.6 Cg_endo -69.72 -44.2 2.24 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.05 138.81 43.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -132.84 132.96 42.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -44.04 110.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 9.8 tpt85 -81.36 92.21 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -131.5 172.27 12.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.77 41.57 0.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 26.5 t -91.98 131.72 37.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.2 p -142.68 153.85 43.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -79.55 -112.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -99.58 86.22 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.1 t -85.12 128.12 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.841 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.61 50.43 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.67 -47.9 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -99.77 130.41 26.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.613 0.721 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.466 ' HD3' ' NE1' ' A' ' 291' ' ' TRP . 53.2 Cg_endo -69.79 138.46 37.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 73.5 m -84.27 143.44 29.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.63 139.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 88.21 -19.09 37.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.463 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -83.61 142.6 30.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.25 137.15 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -132.66 162.69 30.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -92.18 138.65 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.8 165.5 29.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.5 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -134.2 148.85 50.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 275' ' ' ILE . 31.4 t -74.71 112.26 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 68.6 p -92.25 -35.02 14.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.6 m -149.24 125.61 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 272' ' ' VAL . 3.8 mp -93.01 120.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.152 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -109.87 153.56 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.837 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -52.67 -39.56 62.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 276' ' ' MET . 1.4 p90 -77.01 -58.59 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -143.17 -165.07 10.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 309' ' ' VAL . 29.9 p -127.08 131.71 50.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 0.0 110.894 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 294' ' ' LEU . 23.2 m-85 -78.33 110.53 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.08 125.69 60.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.91 126.4 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 291' ' ' TRP . 57.8 mt -73.58 154.36 39.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.87 147.05 50.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.01 -48.89 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.55 143.3 50.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -58.43 -46.46 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -88.89 126.05 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -69.5 96.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.466 ' NE1' ' HD3' ' A' ' 262' ' ' PRO . 84.3 m95 -91.5 137.66 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -121.39 116.46 24.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -116.53 159.13 14.08 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.547 HD13 ' CE1' ' A' ' 281' ' ' PHE . 13.3 tp -113.66 146.09 40.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 31.7 t -121.1 104.22 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -57.18 151.76 14.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.39 -22.9 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 14.9 m -69.69 -38.44 77.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 299' ' ' GLU . 10.3 mp0 -85.22 27.71 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 312' ' ' VAL . 40.7 mt -118.21 -50.16 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -93.93 161.21 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.58 -62.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -128.68 55.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -170.26 178.89 42.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -119.86 153.75 35.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 312' ' ' VAL . 20.4 t -145.65 136.28 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -51.21 -59.52 4.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.672 ' ND2' ' HB3' ' A' ' 310' ' ' ALA . 0.4 OUTLIER -153.86 163.93 39.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 313' ' ' VAL . 18.8 t -54.85 -34.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.672 ' HB3' ' ND2' ' A' ' 308' ' ' ASN . . . -37.9 -58.87 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.63 -26.13 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.69 HG12 HG13 ' A' ' 313' ' ' VAL . 76.9 t -68.62 -63.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 309' ' ' VAL . 29.6 m -117.93 156.06 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 7.8 t -110.62 176.16 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -87.57 124.82 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 80.09 29.59 45.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.13 132.78 50.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -76.01 140.0 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.4 m -153.85 163.54 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -110.92 128.62 55.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.538 HG12 ' HG2' ' A' ' 335' ' ' MET . 27.1 m -130.38 166.57 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.474 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 11.9 ttmm -125.31 144.91 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.464 ' N ' ' HG2' ' A' ' 322' ' ' LYS . 93.2 t -78.6 106.07 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.02 -43.05 55.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.4 t -173.73 142.98 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . 0.423 ' CZ ' ' CH2' ' A' ' 291' ' ' TRP . 14.8 t80 -123.88 116.21 22.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 327' ' ' THR . 4.7 t -129.08 113.97 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 54.86 -111.52 2.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 33.5 p -107.41 39.34 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . 0.418 ' HB3' HG23 ' A' ' 327' ' ' THR . 21.9 ttmm -137.0 109.76 7.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 8.0 m -113.97 107.02 15.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.3 t -81.1 155.56 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.2 mt -146.29 143.68 29.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 88.7 p -118.37 140.08 50.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.538 ' HG2' HG12 ' A' ' 321' ' ' VAL . 80.6 mtp -109.66 -56.82 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 337' ' ' ASP . 56.2 pttt -51.81 -39.39 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 336' ' ' LYS . 0.8 OUTLIER -69.82 -17.58 63.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 80.6 t -116.0 101.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -46.31 158.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -110.66 -13.04 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -84.86 -31.37 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 29.9 p -133.27 -34.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.187 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.98 15.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 345' ' ' ASP . 7.4 tp10 -89.61 157.86 17.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 344' ' ' GLU . 9.2 t0 -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.6 32.71 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -111.62 81.79 3.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.717 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -12.51 33.15 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.703 2.269 . . . . 0.0 112.314 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -173.57 160.61 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -139.05 116.52 11.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -59.23 139.57 56.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -105.59 87.0 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -91.24 138.68 31.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.26 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.0 m -105.81 101.08 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.883 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.4 t -104.61 -44.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -86.68 101.82 2.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 90.7 p -120.28 -57.91 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.901 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 53.1 p -108.48 81.6 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 39.37 69.53 0.41 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -121.46 -52.4 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -108.47 144.44 29.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.623 0.725 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -174.94 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 92.2 m -134.17 139.84 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 65.5 mt -68.2 141.24 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.78 -10.59 31.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.48 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -90.25 142.65 27.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.763 0.315 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 343' ' ' GLY . 68.8 mt -92.14 128.04 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.118 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 323' ' ' VAL . 79.2 m-85 -124.4 164.18 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.32 141.39 28.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -148.42 -176.58 21.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -150.29 139.17 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 275' ' ' ILE . 41.9 t -69.95 120.66 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' THR . . . . . . . . . . . . . 71.6 p -102.87 -31.76 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.2 m -147.82 129.99 15.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 309' ' ' VAL . 3.7 mp -101.54 120.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 278' ' ' PHE . 9.4 mmt -110.93 152.71 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -15.18 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 276' ' ' MET . 3.1 p90 -102.51 -54.59 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . -149.58 174.37 29.11 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.624 ' HB3' HG11 ' A' ' 309' ' ' VAL . 18.5 p -114.71 136.87 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 294' ' ' LEU . 52.1 m-85 -85.26 113.63 21.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.92 116.48 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.05 131.08 34.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 291' ' ' TRP . 76.2 mt -71.89 145.19 48.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -116.7 153.26 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.98 -61.79 1.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 73.8 mt -45.54 149.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -72.27 -34.28 68.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -92.81 101.5 13.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -54.2 107.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 284' ' ' LEU . 46.5 m95 -103.6 164.99 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -149.67 116.53 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -113.92 171.79 13.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' A' ' 281' ' ' PHE . 14.5 tp -124.09 137.23 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.953 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.06 98.72 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -54.51 162.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 7.4 tt -60.95 -24.26 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 46.9 t -80.05 -5.37 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . 0.42 ' C ' ' HG3' ' A' ' 336' ' ' LYS . 80.5 mt-10 -107.92 32.03 5.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 1.041 HD13 HG11 ' A' ' 312' ' ' VAL . 77.5 mt -122.29 -55.05 1.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -152.77 149.53 28.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 303' ' ' GLU . 1.0 OUTLIER -45.87 166.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 304' ' ' GLY . 16.5 mt-10 -35.02 -69.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 303' ' ' GLU . . . 34.44 -107.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -172.97 120.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' CG ' ' A' ' 301' ' ' ARG . 86.5 t -146.41 130.5 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -57.88 -74.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 312' ' ' VAL . 0.0 OUTLIER -159.33 -179.85 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 313' ' ' VAL . 4.0 t -57.82 -41.22 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -47.74 -51.16 23.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 22.88 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.041 HG11 HD13 ' A' ' 300' ' ' LEU . 73.9 t -124.47 -55.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 309' ' ' VAL . 35.5 m -116.71 176.07 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 72.9 m -125.79 152.37 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -69.28 131.53 45.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 62.83 34.32 89.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -104.93 128.6 53.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.923 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.11 120.42 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 25.2 m -136.66 148.0 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -98.64 137.81 36.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.747 HG21 HD13 ' A' ' 333' ' ' LEU . 30.3 m -139.13 160.54 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.161 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 338' ' ' VAL . 12.5 ttmm -109.33 132.06 54.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.454 HG23 ' HD1' ' A' ' 268' ' ' TYR . 30.2 t -67.27 104.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 334' ' ' SER . 66.1 mt -73.54 -54.72 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -158.54 142.7 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 117.24 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 327' ' ' THR . 6.9 t -138.48 108.67 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 56.38 -142.54 39.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.441 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 66.0 p -74.43 -5.19 41.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -95.51 126.58 40.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 10.1 m -124.28 121.61 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.1 m -83.66 146.03 28.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.747 HD13 HG21 ' A' ' 321' ' ' VAL . 88.3 mt -145.14 138.71 26.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.777 ' HB2' HD11 ' A' ' 324' ' ' LEU . 35.0 t -126.75 144.48 50.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' MET . . . . . 0.412 ' CG ' HG12 ' A' ' 321' ' ' VAL . 91.0 mtp -106.31 -34.1 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 299' ' ' GLU . 4.9 mtmp? -54.37 -27.82 39.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -97.66 23.82 7.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 322' ' ' LYS . 43.9 t -150.72 140.79 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -96.31 142.22 28.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -88.86 30.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.14 -57.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 44.7 p -122.34 -27.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 267' ' ' ILE . . . 97.34 30.5 7.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -82.49 151.78 26.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.13 106.43 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 63.8 mt -80.61 -34.63 34.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 347' ' ' ASN . 1.0 OUTLIER -116.04 83.57 12.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.911 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.91 2.99 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.73 105.46 11.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.404 ' CA ' HD21 ' A' ' 347' ' ' ASN . 16.9 ptt85 -97.97 174.14 6.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -146.9 130.85 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -123.46 146.54 47.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.08 156.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.9 tp -106.07 -51.29 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.847 . . . . . . . . 0 0 . 1 stop_ save_